Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

 
   volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             1110 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormalities in the modular neocortical organization of the brain in patients with schizophrenia Roy, E.
 2003
 60 1S p. 74-
1 p.
 artikel
2 Abnormalities of antisaccade task performance in schizophrenia and bipolar illness Martin, L.F.
 2003
 60 1S p. 267-
1 p.
 artikel
3 Abnormal limbic system connectivity in schizophrenia Medoff, D.R.
 2003
 60 1S p. 228-229
2 p.
 artikel
4 Abnormal oral glucose tolerance tests in first episode, drug naive patients with schizophrenia Spelman, L.M.
 2003
 60 1S p. 51-
1 p.
 artikel
5 Abnormal white matter integrity in schizophrenia and schizoaffective disorder revealed by diffusion tensor imaging Nierenberg, J.
 2003
 60 1S p. 203-
1 p.
 artikel
6 A case-control study of seasonality effects on schizophrenic births in a tropical island Carrion-Baralt, J.R.
 2003
 60 1S p. 36-
1 p.
 artikel
7 Access and store characteristics of semantic memory deficits across illness duration in schizophrenia Leeson, V.
 2003
 60 1S p. 143-
1 p.
 artikel
8 A centralized in facility to aid data sharing and coordination in psychiatric research Smalheiser, N.R.
 2003
 60 1S p. 345-
1 p.
 artikel
9 A cerebral 31-phosphorus magnetic resonance spectroscopy study of patients with schizophrenia who have seriously and dangerously violently offended Puri, B.K.
 2003
 60 1S p. 245-
1 p.
 artikel
10 A chromosome 2P susceptibility locus for schizophrenia: Evidence for genetic heterogeneity in extended pedigrees from a Pacific island isolate Myles-Worsley, M.
 2003
 60 1S p. 87-88
2 p.
 artikel
11 A comparison of adherence and persistence levels among schizophrenia patients treated with atypical antipsychotics Zhu, B.
 2003
 60 1S p. 349-
1 p.
 artikel
12 A comparison of anomalous experiences in individuals with and without a diagnosis of psychotic disorder Brett, C.
 2003
 60 1S p. 12-
1 p.
 artikel
13 A comparison of bupropion SR and placebo for smoking cessation in schizophrenia Weiner, E.
 2003
 60 1S p. 305-306
2 p.
 artikel
14 A comparison of implicit and explicit nonverbal memory in schizophrenic patients and their first-degree relatives Robles, O.
 2003
 60 1S p. 154-
1 p.
 artikel
15 A comparison of olanzapine versus risperidone on improvement in negative symptoms and emotional discomfort in patients with schizophrenia Ahmed, S.
 2003
 60 1S p. 270-
1 p.
 artikel
16 A comparison of patients with type two diabetes and schizophrenia, major affective disorder and no mental illness Dixon, L.
 2003
 60 1S p. 335-
1 p.
 artikel
17 A comparison of psychological profiles between suicide ideators and non-ideators among psychiatric patients: A preliminary report Heidi, C.
 2003
 60 1S p. 337-
1 p.
 artikel
18 A comparison of second-generation antipsychotic use between two differing systems of care for people with severe psychosis: The Australia and state of Maryland perspective Conley, R.R.
 2003
 60 1S p. 36-37
2 p.
 artikel
19 A comparison of the effects of risperidone and its major metabolite, 9-hydroxy-risperidone, on dopamine release in the rat prefrontal cortex Saklayen, S.S.
 2003
 60 1S p. 114-
1 p.
 artikel
20 A computational model of the role of dopamine and psychotropic drugs in modulating motivated action Becker, S.
 2003
 60 1S p. 164-
1 p.
 artikel
21 A contrasting model for deficit symptoms in leadership, with sex-hormonal dysgenesis/variation as a determinant Alias, A.
 2003
 60 1S p. 163-164
2 p.
 artikel
22 ACP-103, A 5-HT2A receptor inverse agonist, a novel potential treatment for psychosis Vanover, K.E.
 2003
 60 1S p. 317-
1 p.
 artikel
23 Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects Kiang, M.
 2003
 60 1S p. 358-
1 p.
 artikel
24 Acute antipsychotic-emergent weight gain and improved emotional and functional status in males and females treated for schizophrenic disorders Ascher-Svanum, H.
 2003
 60 1S p. 351-
1 p.
 artikel
25 Acute effects of antipsychotics and diazepam on prepulse inhibition of the startle response Kristiansen, K.T.
 2003
 60 1S p. 100-
1 p.
 artikel
26 Acute prenatal maternal stress and functional outcome in young adult life: A population based study Reichenberg, A.
 2003
 60 1S p. 49-
1 p.
 artikel
27 Acute response to olanzapine predicts continued improvement in schizophrenia Zhao, Z.
 2003
 60 1S p. 308-
1 p.
 artikel
28 Adjunctive use of oxcarbazepine in schizophrenia Koethe, D.
 2003
 60 1S p. 290-
1 p.
 artikel
29 Adolescent inpatients with schizophrenia treated with olanzapine: Further results from an ongoing multicenter study Dittmann, R.W.
 2003
 60 1S p. 281-
1 p.
 artikel
30 A double blind study comparing olanzapine to haloperidol for reducing cue-elicited craving in individuals with schizophrenia and cocaine dependence Smelson, D.A.
 2003
 60 1S p. 303-
1 p.
 artikel
31 A dry land spatial navigation task for cognitive assessments in the mouse Elmer, G.
 2003
 60 1S p. 168-169
2 p.
 artikel
32 A follow-up study of basal ganglia volumes and extrapyramidal symptoms in schizophrenia patients treated with risperidone or olanzapine Lang, D.J.
 2003
 60 1S p. 200-
1 p.
 artikel
33 Age and treatment related local hippocampal changes in schizophrenia explained by a novel shape analysis method Styner, M.
 2003
 60 1S p. 208-
1 p.
 artikel
34 Age predicts transition to psychosis in prodromal schizophrenia Amminger, G.
 2003
 60 1S p. 32-33
2 p.
 artikel
35 Age related decline of severity of positive symptoms with a stable course of cognitive impairment in schizophrenia Alptekin, K.
 2003
 60 1S p. 122-
1 p.
 artikel
36 A goal-directed behaviour model of neurocognitive and behavioural functioning in first episode psychosis — A preliminary report of the first study Purvis, R.G.
 2003
 60 1S p. 153-
1 p.
 artikel
37 A latent factor analysis of the deficit syndrome criteria Yale, S.A.
 2003
 60 1S p. 30-
1 p.
 artikel
38 Alcohol and substance abuse patterns in schizophrenia Lawson, W.B.
 2003
 60 1S p. 20-
1 p.
 artikel
39 Alert effect and schizophrenia Peretti, C.
 2003
 60 1S p. 177-
1 p.
 artikel
40 Alterations of glucose metabolism during treatment with clozapine versus amisulpride Oehl, M.A.
 2003
 60 1S p. 364-
1 p.
 artikel
41 Altered acoustic startle response in mice partially deficient for glycine transporter 1 Vanhoof, G.
 2003
 60 1S p. 118-
1 p.
 artikel
42 Altered expression of NMDA receptor subunits and associated post synaptic density proteins in schizophrenia and rats exposed in utero to methylazoxymethanol acetate Clinton, S.M.
 2003
 60 1S p. 105-
1 p.
 artikel
43 Altered gene expression in parvalbumin-containing GABA neurons in the prefrontal cortex of subjects with schizophrenia Hashimoto, T.
 2003
 60 1S p. 71-
1 p.
 artikel
44 Altered neuronal organisation of the brain of adolescents born very preterm during response inhibition Nosarti, C.
 2003
 60 1S p. 230-
1 p.
 artikel
45 Altered physiologic activity in a distributed neural system during working memory processing in patients with first-episode schizophrenia Cannon, T.D.
 2003
 60 1S p. 214-
1 p.
 artikel
46 A maximum tolerated dose study of SM-13496 in patients with schizophrenia Jhee, S.S.
 2003
 60 1S p. 287-
1 p.
 artikel
47 Amelioration of hypofrontality in schizophrenia during cognitive training Hempel, A.
 2003
 60 1S p. 220-221
2 p.
 artikel
48 A meta-analysis comparing “atypical” antipsychotis with low-potency conventional antipsychotics. Is less more? Leucht, S.
 2003
 60 1S p. 293-
1 p.
 artikel
49 A meta-analysis of FMRI studies of verbal fluency: Segregation of activation within inferior frontal gyrus in healthy individuals and people with schizophrenia Costafreda, S.
 2003
 60 1S p. 215-216
2 p.
 artikel
50 A meta-analysis of neuropsychological change with second generation treatment in schizophrenia Woodward, N.D.
 2003
 60 1S p. 307-
1 p.
 artikel
51 A meta-analysis of randomised clinical trials comparing olanzapine with other antipsychotic agents used in the treatment of schizophrenia Croker, V.
 2003
 60 1S p. 279-
1 p.
 artikel
52 A meta-analysis of studies of antisaccade performance in biological relatives of schizophrenia patients Mendell, N.R.
 2003
 60 1S p. 267-
1 p.
 artikel
53 A meta-analysis of the efficacy of olanzapine and ziprasidone in treating schizophrenia Matza, L.
 2003
 60 1S p. 294-295
2 p.
 artikel
54 A meta-analysis of the efficacy of second-generation antipsychotics Glick, I.D.
 2003
 60 1S p. 285-
1 p.
 artikel
55 A method for abbreviating assessment scales: The schizophrenia quality of life scale Bilker, W.B.
 2003
 60 1S p. 165-
1 p.
 artikel
56 A model for in vivo studies of human tyrosine hydroxylase gene expression in psychiatric diseases Meloni, R.
 2003
 60 1S p. 95-96
2 p.
 artikel
57 A motor theory of the origin of schizophrenia van Hoof, J.
 2003
 60 1S p. 161-
1 p.
 artikel
58 Amphetamine- versus phencyclidine-sensitized states: Models of schizophrenia Tenn, C.
 2003
 60 1S p. 116-
1 p.
 artikel
59 A multimodal examination of anterior cingulate cortex correlates of trial-to-trial performance impairments in schizophrenia Cho, R.Y.
 2003
 60 1S p. 215-
1 p.
 artikel
60 Amygdala structure and associated neuropsychological function in schizophrenia Keedy, S.
 2003
 60 1S p. 140-141
2 p.
 artikel
61 Amygdala volume in patients with schizophrenia from multiply affected families and their unaffected relatives Marshall, N.K.
 2003
 60 1S p. 201-
1 p.
 artikel
62 Analysis of FMRI bold activation during the tower of London task using cortical pattern matching Rasser, P.E.
 2003
 60 1S p. 232-
1 p.
 artikel
63 Analysis of muscarinic 1 promoter polymorphisms on receptor expression and outcome to atypical antipsychotic treatment Mancama, D.T.
 2003
 60 1S p. 85-
1 p.
 artikel
64 Analysis of randomized clinical trials with oral and intramuscular (IM) olanzapine in bipolar-affective disorders based on EBM criteria and therapeutic effect calculation Czekalla, J.
 2003
 60 1S p. 279-
1 p.
 artikel
65 Analysis of variants in the promoter of the human alpha7 neuronal nicotinic acetylcholine receptor Littlewood, A.L.
 2003
 60 1S p. 95-
1 p.
 artikel
66 An animal model showing adult-onset dopamine hyperactivity and neuropathological features of schizophrenia Rajakumar, R.N.
 2003
 60 1S p. 58-
1 p.
 artikel
67 An assessment of the auditory P300 equivalent with sparse FMRI imaging Mu¨ller, B.W.
 2003
 60 1S p. 229-
1 p.
 artikel
68 An association study of MAO-A gene polymorphism in methamphetamine psychosis Nakamura, K.
 2003
 60 1S p. 88-
1 p.
 artikel
69 A naturalistic study of response to clozapine following failure to respond to olanzapine Osborne, S.A.
 2003
 60 1S p. 298-
1 p.
 artikel
70 An economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol Russell, J.M.
 2003
 60 1S p. 343-
1 p.
 artikel
71 An educational intervention designed to improve treatment adherence in schizophrenia Collins, A.
 2003
 60 1S p. 321-
1 p.
 artikel
72 An empirical study of the factor structure of negative symptoms and dysphoric mood in schizophrenia, dementia and depression Galynker, I.
 2003
 60 1S p. 16-
1 p.
 artikel
73 A neurodevelopmental, glutamatergic model relevant to schizophrenia? MK801-induced apoptosis in the neonatal rat produces molecular changes in the adult brain Harris, L.W.
 2003
 60 1S p. 57-58
2 p.
 artikel
74 An evaluation of sensory versus motor hypotheses of pursuit deficits O'Driscoll, G.A.
 2003
 60 1S p. 268-
1 p.
 artikel
75 An event-related FMRI study of conscious recollection and familiarity in schizophrenia Vidailhet, P.
 2003
 60 1S p. 236-
1 p.
 artikel
76 An examination of cross-racial differences in cognitive and psychosocial variables across two patient groups with schizophrenia Dobel, D.M.
 2003
 60 1S p. 132-
1 p.
 artikel
77 An exploration of sterotypy and cognitive correlates in patients with first-episode psychosis Good, K.P.
 2003
 60 1S p. 136-
1 p.
 artikel
78 An FMRI paradigm to study responses to aversive stimuli - a central role for limbic striatum Jensen, J.
 2003
 60 1S p. 224-
1 p.
 artikel
79 An FMRI study of language organization in schizophrenia Tagamets, M.
 2003
 60 1S p. 234-235
2 p.
 artikel
80 Anhedonia and illness chronicity measured over twenty years of schizophrenic illness Herbener, E.
 2003
 60 1S p. 17-18
2 p.
 artikel
81 Anhedonia and the subjective experience of emotion in schizophrenia Burbridge, J.A.
 2003
 60 1S p. 127-128
2 p.
 artikel
82 A nine month naturalistic randomized controlled trial comparing olanzapine and conventional antipsychotics for schizophrenia and related disorders Mari, J.D.
 2003
 60 1S p. 294-
1 p.
 artikel
83 An innovative compensatory intervention for rehabilitation in schizophrenia: The effects of errorless learning on work training outcome Kern, R.
 2003
 60 1S p. 172-
1 p.
 artikel
84 An in vivo assessment of aripiprazole, ziprasidone, risperidone and olanzapine in rat assays indicative of 5-HT1A and D2 receptor activity Wolff, M.C.
 2003
 60 1S p. 119-120
2 p.
 artikel
85 An MRI study of internal capsule and thalamus in first-episode and chronic schizophrenia Khorram, B.
 2003
 60 1S p. 198-199
2 p.
 artikel
86 An open-label investigation of the adjuvant therapeutic effects of galantamine in patients with chronic schizophrenia and persistent deficit symptoms Arnold, D.
 2003
 60 1S p. 271-
1 p.
 artikel
87 An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction Byerly, M.
 2003
 60 1S p. 276-
1 p.
 artikel
88 A novel polymorphism in the coding region of the DAP-1 gene (HDLG-and-PSD-95 associated protein-1 gene): Analysis of association with schizophrenia Aoyama, S.
 2003
 60 1S p. 93-
1 p.
 artikel
89 An RCT A group-based intervention for substance abuse in schizophrenia Castle, D.J.
 2003
 60 1S p. 276-277
2 p.
 artikel
90 Antagonism of glycine transporter activity by typical and atypical antipsychotics Williams, J.B.
 2003
 60 1S p. 317-318
2 p.
 artikel
91 Anterior cingulate/paracingulate surface morphology and task difficulty in schizophrenia and healthy controls Yucel, M.
 2003
 60 1S p. 162-
1 p.
 artikel
92 Antigliosis in schizophrenia Holcomb, L.
 2003
 60 1S p. 72-
1 p.
 artikel
93 Antipsychotic-induced D2-receptor upregulation — differential effect of continuous versus transient D2-receptor blockade Ginovart, N.
 2003
 60 1S p. 241-
1 p.
 artikel
94 Antipsychotic-induced type 2 diabetes: Evidence from a large health plan database Gianfrancesco, F.
 2003
 60 1S p. 336-337
2 p.
 artikel
95 Antipsychotic maintenance in schizophrenia: Partial compliance and clinical outcome Docherty, J.
 2003
 60 1S p. 281-282
2 p.
 artikel
96 Antipsychotic medications and diabetes outcomes in the seriously mentally ill Kreyenbuhl, J.
 2003
 60 1S p. 337-338
2 p.
 artikel
97 Antipsychotic polypharmacy in the treatment of schizophrenia Cornell, C.U.
 2003
 60 1S p. 37-
1 p.
 artikel
98 Antipsychotics across the ditch Robinson, G.
 2003
 60 1S p. 343-
1 p.
 artikel
99 Antipsychotics and the calmodulin 2nd messenger system Rushlow, W.
 2003
 60 1S p. 114-
1 p.
 artikel
100 Antipsychotic side effects in children Adami, H.M.
 2003
 60 1S p. 350-
1 p.
 artikel
101 Antipsychotics suppress stimulus incentive salience: Implications for their therapeutic actions in schizophrenia Li, M.
 2003
 60 1S p. 111-
1 p.
 artikel
102 Antipsychotics with different D2 dopamine receptor potency affect differently the postsynaptic density protein homer at glutamatergic metabotropic synapse Fiore, G.
 2003
 60 1S p. 106-
1 p.
 artikel
103 Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia Lieberman, J.
 2003
 60 1S p. 293-
1 p.
 artikel
104 Antipsychotic use and new onset type II diabetes among schizophrenics Lambert, B.L.
 2003
 60 1S p. 359-360
2 p.
 artikel
105 A one-year double-blind comparison of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in patients with schizophrenia Breier, A.
 2003
 60 1S p. 274-275
2 p.
 artikel
106 A pilot neuropsychological study of Kraepelinian and non-Kraepelinian schizophrenia Lehoux, C.
 2003
 60 1S p. 6-
1 p.
 artikel
107 Apoptotic markers in schizophrenia: Elevated CSF levels of BCL-2 in antipsychotic responders but not non-responders Nasrallah, H.A.
 2003
 60 1S p. 101-
1 p.
 artikel
108 A process approach to verbal fluency tasks in patients with schizophrenia Maron, L.M.
 2003
 60 1S p. 145-
1 p.
 artikel
109 A prospective follow-up of quality of life, wellbeing, side effects and compliance in the treatment of first episode psychosis Taylor, T.
 2003
 60 1S p. 329-
1 p.
 artikel
110 A proton magnetic spectroscopy (1H MRS) study of possible white matter pathlolgy in schizophrenia Friedman, J.I.
 2003
 60 1S p. 240-
1 p.
 artikel
111 A psychophysiological study of cognitive deficits in schizophrenia: Perceptual, executive and motor mechanisms Smid, H.G.
 2003
 60 1S p. 183-184
2 p.
 artikel
112 A randomised controlled trial of cognitive behaviour therapy for treatment refractory schizophrenia Valmaggia, L.R.
 2003
 60 1S p. 305-
1 p.
 artikel
113 A randomized clinical trial of a brief cognitive-behavioral treatment for the chronic phase of schizophrenia Gaither, M.L.
 2003
 60 1S p. 322-323
2 p.
 artikel
114 A rat model with relevance to schizophrenia: Low brain glutathione levels during development induce long-term cognitive deficit Do, K.Q.
 2003
 60 1S p. 105-
1 p.
 artikel
115 Are antipsychotics associated with low bone mineral density? Howes, O.D.
 2003
 60 1S p. 357-
1 p.
 artikel
116 Are there differences in cognitive impairments between schizophrenic patients treated with typical or atypical antipsychotics? Brazo, P.
 2003
 60 1S p. 166-
1 p.
 artikel
117 A review of staff training and analysis of risk factors for violent incidents among outpatients with schizophrenia Weisman, R.L.
 2003
 60 1S p. 347-
1 p.
 artikel
118 Aripiprazole: A dopamine-serotonin system stabilizer Kurahashi, N.
 2003
 60 1S p. 312-313
2 p.
 artikel
119 Aripiprazole and risperidone versus placebo in schizophrenia and schizoaffective disorder Potkin, S.G.
 2003
 60 1S p. 300-
1 p.
 artikel
120 Aripiprazole for long-term maintenance treatment of schizophrenia McQuade, R.D.
 2003
 60 1S p. 295-
1 p.
 artikel
121 Aripiprazole in patients with first episode schizophrenia Brown, D.
 2003
 60 1S p. 275-
1 p.
 artikel
122 Aripiprazole versus placebo for relapse prevention in patients with chronic schizophrenia Casey, D.
 2003
 60 1S p. 276-
1 p.
 artikel
123 Aripiprazole versus placebo in acute mania Marcus, R.
 2003
 60 1S p. 293-
1 p.
 artikel
124 A sexually dimorphic ratio of orbital frontal to amygdala volume is altered in schizophrenia Gur, R.C.
 2003
 60 1S p. 196-
1 p.
 artikel
125 Assessing visual masking in schizophrenia with the paracontrast and metacontrast procedures Rassovsky, Y.
 2003
 60 1S p. 154-
1 p.
 artikel
126 Assessment of fat distribution by MRI, and changes in leptin and insulin associated with drug treatment of first episode schizophrenic patients Zhang, Z.
 2003
 60 1S p. 372-
1 p.
 artikel
127 Assessment of neurocognitive decline in the premorbid period of schizophrenia Niendam, T.
 2003
 60 1S p. 151-
1 p.
 artikel
128 Assessment of sexual dysfunctions in schizophrenic inpatients with the AMSP drug safety program Linka, T.
 2003
 60 1S p. 361-362
2 p.
 artikel
129 Association analysis of polymorphism (ARG492CYS) in the α1A-adrenergic receptor gene with schizophrenia and antipsychotic treatment Clark, D.A.
 2003
 60 1S p. 79-80
2 p.
 artikel
130 Association of a D2 receptor gene polymorphism and schizophrenia in the spanish population Arroyo, B.
 2003
 60 1S p. 78-
1 p.
 artikel
131 Association of apolipoproteins D with membrane arachidonic acid levels in schizophrenia Yao, J.K.
 2003
 60 1S p. 103-
1 p.
 artikel
132 Association of NOTCH4 with schizophrenia in VA coop study #366 Young, K.A.
 2003
 60 1S p. 92-
1 p.
 artikel
133 Association study of dysbindin gene (DTBN1) BFAI polymorphism in schizophrenia De Luca, V.
 2003
 60 1S p. 80-
1 p.
 artikel
134 A study of D2 receptor occupancy after multiple oral administration of SLV 310 to healthy male volunteers, using11C-raclopride by means of positron emission tomography (PET) Bakker, J.
 2003
 60 1S p. 238-
1 p.
 artikel
135 A study of the interaction between disrupted in schizophrenia 1 (DISC1) and the Lis1 associated protein NUDEL Handford, E.
 2003
 60 1S p. 62-
1 p.
 artikel
136 A systematic evaluation of oxidative stress indices in biological samples Cheng, P.
 2003
 60 1S p. 61-
1 p.
 artikel
137 A systematic review of risperidone for schizophrenia Hunter, R.
 2003
 60 1S p. 286-
1 p.
 artikel
138 A test of a culturally appropriate family sponsorship program for Caucasian and Vietnamese caregivers of persons with schizophrenia Stein, M.K.
 2003
 60 1S p. 328-329
2 p.
 artikel
139 A TMS study of abnormal plasticity in schizophrenia Fitzgerald, P.B.
 2003
 60 1S p. 250-
1 p.
 artikel
140 Attentional dysfunction, dual-task performance, and functional outcome in recent-onset schizophrenia Nuechterlein, K.H.
 2003
 60 1S p. 176-177
2 p.
 artikel
141 Attentional performance in prodromal schizophrenia Shafer, K.
 2003
 60 1S p. 183-
1 p.
 artikel
142 Attention and divided attention in schizophrenia Birkett, P.
 2003
 60 1S p. 125-
1 p.
 artikel
143 Attributional style and symptoms as predictors of social function in schizophrenia Lysaker, P.
 2003
 60 1S p. 21-
1 p.
 artikel
144 A two-year follow-up assessment of schizotypic young adults Diaz, M.A.
 2003
 60 1S p. 167-168
2 p.
 artikel
145 Atypical antipsychotic adherence and hospitalization in patients with schizophrenia Tafesse, E.
 2003
 60 1S p. 346-
1 p.
 artikel
146 Atypical antipsychotic and galantamine co-use in Alzheimer's disease Mintzer, J.E.
 2003
 60 1S p. 148-
1 p.
 artikel
147 Atypical antipsychotic medications and memory enhancement in schizophrenia Sepehry, A.A.
 2003
 60 1S p. 158-
1 p.
 artikel
148 Atypical antipsychotic quetiapine in the treatment of psychosis associated with lewy body dementia Baskys, A.
 2003
 60 1S p. 272-273
2 p.
 artikel
149 Atypical antipsychotics and hyperglycemia: Analysis of 11,994 Ohio DMH subjects Wilson, D.R.
 2003
 60 1S p. 370-
1 p.
 artikel
150 Atypical antipsychotics differ in effect on P50 auditory sensory gating Adler, L.E.
 2003
 60 1S p. 248-
1 p.
 artikel
151 Auditing the quality of clozapine treatment in east Yorkshire Mortimer, A.M.
 2003
 60 1S p. 295-296
2 p.
 artikel
152 Audit of antipsychotic use in first episode psychosis Matthiasson, P.
 2003
 60 1S p. 294-
1 p.
 artikel
153 Auditory attention in schizophrenia patients and their first-degree relatives: An event-related potential study Force-Thompson, R.B.
 2003
 60 1S p. 250-
1 p.
 artikel
154 Auditory cortex in schizophrenia: An unbiased stereologic method for determination of regional and laminar volume changes Sweet, R.A.
 2003
 60 1S p. 75-
1 p.
 artikel
155 Auditory hallucinations are not simply due to defective self-monitoring Allen, P.
 2003
 60 1S p. 164-
1 p.
 artikel
156 Auditory response showing brain source abnormalities in schizophrenia Huang, M.
 2003
 60 1S p. 223-
1 p.
 artikel
157 Auditory sensory gating deficit and negative symptoms in schizophrenia Ricker, D.
 2003
 60 1S p. 258-
1 p.
 artikel
158 Author index 2003
 60 1S p. 373-392
20 p.
 artikel
159 Autobiographical memory in schizophrenia: Semantic priming and episodic memory effects Madeley, L.K.
 2003
 60 1S p. 174-175
2 p.
 artikel
160 Automatic versus controlled priming in individuals with schizophrenia Melinder, M.R.
 2003
 60 1S p. 147-
1 p.
 artikel
161 Automatization and information processing capacity in schizophrenia van Raalten, T.
 2003
 60 1S p. 236-
1 p.
 artikel
162 Ave5997, a dopamine D3 antagonist for the treatment of schizophrenia Kongsamut, S.
 2003
 60 1S p. 312-
1 p.
 artikel
163 A videotaped neurologic exam in schizophrenia, schizoaffective, bipolar and control subjects Olson, S.C.
 2003
 60 1S p. 23-
1 p.
 artikel
164 A videotape intervention to enhance the informed consent process for patients participating in clinical research trials Wirshing, D.A.
 2003
 60 1S p. 306-
1 p.
 artikel
165 Avoidant personality disorder increases the detection of first degree relatives affected by a schizophrenia spectrum diagnosis Fogelson, D.L.
 2003
 60 1S p. 80-81
2 p.
 artikel
166 AX-CPT performance in schizophrenics varies with cue complexity Dias, E.C.
 2003
 60 1S p. 167-
1 p.
 artikel
167 Behavioral and psychophysiological responses to a spatial working memory task in children and adolescents with schizophrenia and high-risk individuals White, T.
 2003
 60 1S p. 185-
1 p.
 artikel
168 Behavioural and electrophysiological explorations of semantic dysfunctions in schizophrenia Kumar, N.
 2003
 60 1S p. 254-
1 p.
 artikel
169 Beliefs about voices and depression in schizophrenia: The role of self-esteem Fannon, D.
 2003
 60 1S p. 169-
1 p.
 artikel
170 Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia Rosenthal, M.H.
 2003
 60 1S p. 301-
1 p.
 artikel
171 Bilateral recruitment of speech and language areas on a verbal fluency task using FMRI in schizophrenic subjects Chua, S.E.
 2003
 60 1S p. 215-
1 p.
 artikel
172 Binocular rivalry is slower in first-degree relatives of schizophrenics Wright, P.
 2003
 60 1S p. 162-
1 p.
 artikel
173 Bioactive lipids and cognitive function in first-episode psychosis Proffitt, T.
 2003
 60 1S p. 153-
1 p.
 artikel
174 Biosocial pathways to functional outcome in schizophrenia: A path analytic model Brekke, J.S.
 2003
 60 1S p. 166-
1 p.
 artikel
175 Birth complications and premorbid functioning in patients with psychotic disorders Walshe, M.
 2003
 60 1S p. 54-55
2 p.
 artikel
176 Blockade of glycine type-1 transporters augments NMDA receptor-mediated neuronal responses in vivo Hertel, P.
 2003
 60 1S p. 107-
1 p.
 artikel
177 Bold FMRI activation in schizotypal personality disorder patients during a visuospatial working memory task Koenigsberg, H.W.
 2003
 60 1S p. 226-
1 p.
 artikel
178 Brain activation during verbal encoding Heinze, S.
 2003
 60 1S p. 220-
1 p.
 artikel
179 Brain activation patterns associated with listening to trauma-related words in patients with schizophrenia and healthy controls: A preliminary FMRI study Flashman, L.A.
 2003
 60 1S p. 217-
1 p.
 artikel
180 Brain structural correlates of IQ in healthy and schizophrenic adolescents Frangou, S.
 2003
 60 1S p. 194-
1 p.
 artikel
181 Caffeine disrupts P50 suppression in normal subjects Ghisolfi, E.S.
 2003
 60 1S p. 251-
1 p.
 artikel
182 Calcification and gliosis in the hippocampus of adult rats with neonatal excitotoxic injury Nayak, S.
 2003
 60 1S p. 58-
1 p.
 artikel
183 Calculating responder days for cost-effectiveness studies Nyhuis, A.W.
 2003
 60 1S p. 341-
1 p.
 artikel
184 Cannabinoids and psychosis: Pharmacological studies with IV delta-9-THC in humans D'Souza, D.C.
 2003
 60 1S p. 310-
1 p.
 artikel
185 Cannabis use in adolescence and risk for adult psychosis: A birth cohort study Cannon, M.
 2003
 60 1S p. 35-
1 p.
 artikel
186 Can stable patients with schizophrenia improve? The impact of partial compliance versus constant therapy Remington, G.
 2003
 60 1S p. 300-
1 p.
 artikel
187 Can we reduce the risks of developing coronary heart disease (CHD) in people with schizophrenia? Walker, L.
 2003
 60 1S p. 54-
1 p.
 artikel
188 Caudate neurochemistry, clinical symptoms, and neuropsychological functioning in first episode schizophrenia: A proton magnetic resonance spectroscopy study Jung, R.E.
 2003
 60 1S p. 241-242
2 p.
 artikel
189 CDNA microarray assessment of MRNA degradation in postmortem brain tissue Catts, V.S.
 2003
 60 1S p. 60-61
2 p.
 artikel
190 Cerebellar lobe morphology and its relation to symptoms in schizophrenia Pierson, R.
 2003
 60 1S p. 205-
1 p.
 artikel
191 Cerebellar timing deficits in schizophrenia O'Leary, D.S.
 2003
 60 1S p. 177-
1 p.
 artikel
192 Cerebral tissue alterations and daily life stress experience in psychosis Marcelis, M.C.
 2003
 60 1S p. 201-
1 p.
 artikel
193 Certification of raters on the PANSS rating scale: Lessons learned from multiple global clinical trials in schizophrenia Kalali, A.H.
 2003
 60 1S p. 288-
1 p.
 artikel
194 Challenges in dimensional approaches to the diagnosis of schizophrenia Ingraham, L.J.
 2003
 60 1S p. 18-
1 p.
 artikel
195 Change in clinical status and side effects of patients treated with either olanzapine or risperidone: Six-month results from the three-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study Gargoloff, P.R.
 2003
 60 1S p. 283-284
2 p.
 artikel
196 Changes in decisional capacity during medication-free schizophrenia research Moser, D.J.
 2003
 60 1S p. 149-150
2 p.
 artikel
197 Changes in different areas of functioning in schizophrenia patients treated with social skills training La¨chler, M.D.
 2003
 60 1S p. 324-
1 p.
 artikel
198 Changes in morphology of the thalamus over time in subjects with neuroleptic naive schizophrenia: Effects of neuroleptic treatment Cherascu, G.
 2003
 60 1S p. 191-192
2 p.
 artikel
199 Changes in the incidence of schizophrenia in British Columbia: 1907 to 1913 Smith, G.N.
 2003
 60 1S p. 50-
1 p.
 artikel
200 Changing voices: A randomised control trial of group cognitive behavioural treatment Wykes, T.
 2003
 60 1S p. 331-
1 p.
 artikel
201 Childhood abuse as a risk factor for psychotic experiences Janssen, I.
 2003
 60 1S p. 40-
1 p.
 artikel
202 Childhood behaviour in a 22Q deletion syndrome subtype of schizophrenia Gheorghiu, M.
 2003
 60 1S p. 81-
1 p.
 artikel
203 Childhood head injury and illness expression in familial schizophrenia AbdelMalik, P.
 2003
 60 1S p. 77-
1 p.
 artikel
204 Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the NMDA receptor antagonist MK-801 in mice Lara, D.R.
 2003
 60 1S p. 110-111
2 p.
 artikel
205 Circadian heart rate patterns and schizophrenia Addis, S.
 2003
 60 1S p. 3-
1 p.
 artikel
206 Clinical and cognitive correlates of real-life functional deficits in schizophrenia patients Light, G.A.
 2003
 60 1S p. 143-
1 p.
 artikel
207 Clinical and functional status over the first three months of treatment: Results from the schizophrenia outpatient health outcomes (SOHO) study Edgell, E.T.
 2003
 60 1S p. 282-
1 p.
 artikel
208 Clinical and psychophysiology correlates of a large cavum septum pellucidum in schizophrenia Crippa, J.A.
 2003
 60 1S p. 192-
1 p.
 artikel
209 Clinical applications of pharmacogenetics: Pre-treatment prediction of antipsychotic response Arranz, M.J.
 2003
 60 1S p. 77-
1 p.
 artikel
210 Clinical characteristics and hospital based resource use among older adults with schizophrenia and schizoaffective disorder, bipolar disorder, depression and dementia Sajatovic, M.
 2003
 60 1S p. 344-
1 p.
 artikel
211 Clinical correlates of adherence to antipsychotic treatment in pre-discharge patients with schizophrenia Faruqui, R.A.
 2003
 60 1S p. 322-
1 p.
 artikel
212 Clinical correlates of comorbid substance use in first episode schizophrenia Barnes, T.R.
 2003
 60 1S p. 11-
1 p.
 artikel
213 Clinical correlates of neurological soft signs in schizophrenia: A multiple regression analysis Krebs, M.E.
 2003
 60 1S p. 83-
1 p.
 artikel
214 Clinical correlates of weight gain in first episode psychosis patients treated with olanzapine Zipursky, R.
 2003
 60 1S p. 372-
1 p.
 artikel
215 Clinical course patterns of schizophrenia Radulescu, E.
 2003
 60 1S p. 25-
1 p.
 artikel
216 Clinical predictors of cognitive function change in schizophrenia Prihoda, T.J.
 2003
 60 1S p. 152-153
2 p.
 artikel
217 Clinicial outcome, service use and costs of care-follow-up data from the Australian scap de Castella, A.R.
 2003
 60 1S p. 334-
1 p.
 artikel
218 Clozapine and olanzapine improve insufficient inhibitory processing of the P20-N40 auditory evoked potential: Evidence for a nicotinic mechanism Simosky, J.
 2003
 60 1S p. 260-
1 p.
 artikel
219 Clozapine and risperidone in moderately refractory schizophrenia: A six month double-blind comparison Schooler, N.R.
 2003
 60 1S p. 302-
1 p.
 artikel
220 Clozapine-associated seizures in a 22Q deletion syndrome subtype of schizophrenia Caluseriu, O.
 2003
 60 1S p. 79-
1 p.
 artikel
221 Clozapine augmentation with risperidone in refractory schizophrenia Josiassen, R.
 2003
 60 1S p. 288-
1 p.
 artikel
222 Clozapine fails to block psychostimulant-induced disruption of auditory sensory gating in the rat Shepard, P.D.
 2003
 60 1S p. 259-260
2 p.
 artikel
223 Clozapine limits alcohol drinking in hamsters: Implications for treatment of schizophrenia Green, A.I.
 2003
 60 1S p. 312-
1 p.
 artikel
224 Clozapine use in clinical trials versus real-world clinical settings Yu, Y.
 2003
 60 1S p. 307-
1 p.
 artikel
225 Cognitive and functional changes in older patients with schizophrenia: Evidence for cognitive threshold effects on functional decline? Harvey, P.D.
 2003
 60 1S p. 137-138
2 p.
 artikel
226 Cognitive basis of hallucinations in schizophrenia: Role of top-down processing Aleman, A.
 2003
 60 1S p. 163-
1 p.
 artikel
227 Cognitive-behavioural therapy in the pre-psychotic phase: An exploratory study Bechdolf, A.
 2003
 60 1S p. 319-
1 p.
 artikel
228 Cognitive biases involved in the formation of delusional beliefs Peters, E.
 2003
 60 1S p. 178-
1 p.
 artikel
229 Cognitive changes in early onset schizophrenia (EOS): A follow-up study Donaldson, S.
 2003
 60 1S p. 132-
1 p.
 artikel
230 Cognitive decline is associated with reduction in global white matter volume in schizophrenia MacCabe, J.H.
 2003
 60 1S p. 144-145
2 p.
 artikel
231 Cognitive deficits associated with schizophrenia in adults with velocardio-facial syndrome van Amelsvoort, T.
 2003
 60 1S p. 91-
1 p.
 artikel
232 Cognitive dysfunctions in recent onset schizophrenia: Performance of unmedicated patients compared to medicated patients and healthy controls: A cross-sectional study Daban, C.
 2003
 60 1S p. 279-280
2 p.
 artikel
233 Cognitive enhancement trial with guanfacine in SPD Siever, L.J.
 2003
 60 1S p. 315-316
2 p.
 artikel
234 Cognitive impairments in adult first-degree relatives of schizophrenia patients: A meta-analytic review Snitz, B.E.
 2003
 60 1S p. 158-
1 p.
 artikel
235 Cognitive markers of illness and disability in schizophrenia Gold, J.M.
 2003
 60 1S p. 135-136
2 p.
 artikel
236 Cognitive profiles in first episode mania: A comparison of schizoaffective and bipolar disorder Eide, P.
 2003
 60 1S p. 133-
1 p.
 artikel
237 Cognitive rehabilitation in schizophrenia Sartory, G.
 2003
 60 1S p. 155-
1 p.
 artikel
238 Cognitive rehabilitation in schizophrenia: A comparison of two methods Bryson, G.
 2003
 60 1S p. 320-
1 p.
 artikel
239 Cognitive remediation and sensory processing deficits in schizophrenia Revheim, N.
 2003
 60 1S p. 180-
1 p.
 artikel
240 Cognitive sub-components in solving the tower of London test — An FMRI study in healthy volunteers and patients with schizophrenia Thienel, R.
 2003
 60 1S p. 235-
1 p.
 artikel
241 Cognitive therapy in ultra high risk individuals for psychosis: Randomised controlled trial Morrison, A.P.
 2003
 60 1S p. 326-
1 p.
 artikel
242 Coherence of co-familial phenotypes in schizophrenia: Craniofacial dysmorphology, though disorder, and smooth pursuit eye movements Deutsch, C.K.
 2003
 60 1S p. 80-
1 p.
 artikel
243 Combined spect and MRS study of subcortical dopamine dysregulation in schizophrenia Kegeles, L.S.
 2003
 60 1S p. 242-
1 p.
 artikel
244 Community psychiatric nurses' attitudes to depot antipsychotic medication Patel, M.
 2003
 60 1S p. 342-
1 p.
 artikel
245 Comparative assessment of antipsychotic adherence by concentration monitoring, pill count and self-report Lam, Y.F.
 2003
 60 1S p. 313-
1 p.
 artikel
246 Comparative morphometric study of the septum and cavum septi pellucidi in patients with schizophrenia, mood disorders and control subjects Brisch, R.G.
 2003
 60 1S p. 190-
1 p.
 artikel
247 Comparative validity of alternative systems for interpretation of PANSS rated symptoms of schizophrenia White, L.
 2003
 60 1S p. 30-
1 p.
 artikel
248 Comparing hippocampal and amygdala volumes of chronically treated patients with schizophrenia to early schizophrenia patients utilizing MRI: Examining a possible contribution of antipsychotic treatment Lauriello, J.
 2003
 60 1S p. 200-
1 p.
 artikel
249 Comparision of depressive symptoms in schizophrenic patients and patients with major depressive disorder Szafranski, T.
 2003
 60 1S p. 27-
1 p.
 artikel
250 Comparison of auditory and visually guided saccades and antisaccades in schizophrenic and control subjects Roberts, B.
 2003
 60 1S p. 268-
1 p.
 artikel
251 Comparison of behavioral effects of olanzapine and clozapine in a genetic model of NMDA receptor hypofunction Duncan, G.E.
 2003
 60 1S p. 311-
1 p.
 artikel
252 Comparison of Golgi stains of human and non-human primates Dwork, A.J.
 2003
 60 1S p. 70-
1 p.
 artikel
253 Comparison of olanzapine and quetiapine antipsychotic treatments for schizophrenia: Six-month results from the three-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study Boland, J.
 2003
 60 1S p. 274-
1 p.
 artikel
254 Comparison of script knowledge and script execution of a daily activity in schizophrenia Semkovska, M.
 2003
 60 1S p. 157-
1 p.
 artikel
255 Comparison of the Dickson glazer sexual functioning inventory (DGSFI) to a standardised clinical interview in assessing sexual functioning in atypical-treated patients: A criterion-related validity study Demers, M.
 2003
 60 1S p. 354-
1 p.
 artikel
256 Comparison of the effects of ziprasidone and haloperidol on regional fos expression in rat forebrain Jennings, C.A.
 2003
 60 1S p. 312-
1 p.
 artikel
257 Complementary neural processes in schizophrenia working memory Fuller, R.
 2003
 60 1S p. 170-
1 p.
 artikel
258 Complement system and circulating immune complexes under schizophrenia: Family study Mayilyan, K.
 2003
 60 1S p. 64-65
2 p.
 artikel
259 Complexins I and II in hippocampus in schizophrenia Sawada, K.
 2003
 60 1S p. 74-75
2 p.
 artikel
260 Complex semantic verbal fluency correlates with FMRI bold activation during empathy tasks in schizophrenia Parks, R.W.
 2003
 60 1S p. 230-231
2 p.
 artikel
261 Compromised frontal white matter integrity in adolescents with early-onset schizophrenia: A controlled diffusion tensor imaging study Kumra, S.
 2003
 60 1S p. 199-
1 p.
 artikel
262 Computerized neurocognitive assessment: Clinical trials and FMRI applications Bilder, R.M.
 2003
 60 1S p. 124-
1 p.
 artikel
263 COMT and neurocognition: New evidence for a role in visual memory Bates, J.A.
 2003
 60 1S p. 123-
1 p.
 artikel
264 Context-dependent memory impairment in schizophrenia: Analysis of the frontal dysfunction hypothesis Schwartz, B.L.
 2003
 60 1S p. 182-183
2 p.
 artikel
265 Context-processing deficits and decreased prefrontal cortex activity: Specific associations with unmedicated, first-episode schizophrenia and with disorganization symptoms Kerns, J.G.
 2003
 60 1S p. 225-
1 p.
 artikel
266 Context processing deficits associated with hypofrontality in the healthy relatives of schizophrenia patients: An event-related FMRI study MacDonald, A.W.
 2003
 60 1S p. 228-
1 p.
 artikel
267 Contextual processing deficits in schizophrenia: Poor integration of visual information or reduced storage capacity Glahn, D.C.
 2003
 60 1S p. 135-
1 p.
 artikel
268 Contribution of working memory to the performance of Tower of Hanoi in chronic schizophrenia Chan, R.C.
 2003
 60 1S p. 129-
1 p.
 artikel
269 Converting a typical antipsychotic into an atypical one — The critical role of D2 VanderSpek, S.C.
 2003
 60 1S p. 117-118
2 p.
 artikel
270 Coping behavior and symptom outcome in recent-onset schizophrenia Ventura, J.
 2003
 60 1S p. 28-
1 p.
 artikel
271 Coping style and hopelessness as predictors of social function at work in schizophrenia Davis, L.W.
 2003
 60 1S p. 15-
1 p.
 artikel
272 Correlates of mismatch negativity reduction in schizophrenia Todd, J.
 2003
 60 1S p. 261-262
2 p.
 artikel
273 Correlations between RCBF and behavior in drug-free schizophrenic patients Lee, S.M.
 2003
 60 1S p. 227-
1 p.
 artikel
274 Cortical metrics of the cingulate gyrus: Gray matter volume, area, and thickness derived from co-occurrence analysis Hosakere, M.
 2003
 60 1S p. 197-198
2 p.
 artikel
275 Cortical-subcortical dysconnectivity expressed by attenuated cortical c-fos induction by acute amphetamine treatment or acute swim stress in mice with reduced NMDA receptor1 expression Miyamoto, S.
 2003
 60 1S p. 112-113
2 p.
 artikel
276 Cortical surface abnormalities in patients with first episode schizophrenia Nopoulos, P.C.
 2003
 60 1S p. 203-
1 p.
 artikel
277 Corticocerebellar alterations in never-treated young age at onset schizophrenia Venkatasubramanian, G.
 2003
 60 1S p. 211-
1 p.
 artikel
278 Cost-effectiveness of olanzapine compared to risperidone and haloperidol in the treatment of patients with schizophrenia: Results from a U.S. randomized controlled trial Namjoshi, M.
 2003
 60 1S p. 296-
1 p.
 artikel
279 Cost-effectiveness of treating schizophrenia with atypical antipsychotics Lewis, M.
 2003
 60 1S p. 338-339
2 p.
 artikel
280 Craniofacial dysmorphology in schizophrenia: Midline deformation from morphometrics with 3-D facial holography Buckley, P.F.
 2003
 60 1S p. 34-
1 p.
 artikel
281 Criminality in the Helsinki high-risk study Suvisaari, J.M.
 2003
 60 1S p. 51-
1 p.
 artikel
282 Cross-modal generality of the gating deficit in schizophrenia Edgar, C.J.
 2003
 60 1S p. 216-217
2 p.
 artikel
283 Cumulative risk assessment for prediction of development of schizophrenia Freeman, A.M.
 2003
 60 1S p. 4-
1 p.
 artikel
284 Current intellectual functioning and grey and white matter alterations in schizophrenia: A voxel-based morphometry study Antonova, E.
 2003
 60 1S p. 188-189
2 p.
 artikel
285 Cytoarchitectural investigations of the planum temporale in schizophrenia, bipolar disorder and major depressive disorder Beasley, C.
 2003
 60 1S p. 68-
1 p.
 artikel
286 Daily clozapine treatment improves spatial memory deficits produced by hippocampal damage in rats Bardgett, M.E.
 2003
 60 1S p. 56-
1 p.
 artikel
287 Dampened emotional reactivity in schizophrenia: ERP evidence Mathalon, D.H.
 2003
 60 1S p. 255-
1 p.
 artikel
288 DA stabilisers — fourth generation antipsychotic drugs Waters, S.
 2003
 60 1S p. 119-
1 p.
 artikel
289 Day-to-day symptom patterns in psychosis and their relation to psychopathology Tschacher, W.
 2003
 60 1S p. 159-160
2 p.
 artikel
290 Decreased nicotinic receptors in schizophrenia: Consequences for sensory processing and cognition Leonard, S.
 2003
 60 1S p. 94-95
2 p.
 artikel
291 Decreased PAR-4 in the temporal cortex of subjects with schizophrenia Glantz, L.A.
 2003
 60 1S p. 62-
1 p.
 artikel
292 Decreased thalamic expression of the homeo☐ gene DLX1 in psychosis Kromkamp, M.
 2003
 60 1S p. 72-
1 p.
 artikel
293 Decreases in volume and parvalbumin-imunoreactive neurons in the amygdala of schizophrenic and bipolar disorder patients Berretta, S.
 2003
 60 1S p. 68-69
2 p.
 artikel
294 Deficits in mismatch negativity in schizophrenia: Predictor of outcome or result of illness progression? Umbricht, D.
 2003
 60 1S p. 262-
1 p.
 artikel
295 Deficits in regional taste sensitivity in patients with schizophrenia Balderston, K.
 2003
 60 1S p. 122-
1 p.
 artikel
296 Deficits of visual organization in patients with schizophrenia Schechter, I.
 2003
 60 1S p. 182-
1 p.
 artikel
297 Defining the phenotype for paternal age related schizophrenia Malaspina, D.
 2003
 60 1S p. 84-85
2 p.
 artikel
298 Delayed onset hypothesis of antipsychotic action — a hypothesis tested and rejected Agid, O.
 2003
 60 1S p. 309-
1 p.
 artikel
299 Delusions and hallucinations are associated with different patterns of frontal lobe functioning in schizophrenia Cohen, A.S.
 2003
 60 1S p. 130-131
2 p.
 artikel
300 Demographic predictors of response to medication withdrawal Donohue, A.
 2003
 60 1S p. 15-
1 p.
 artikel
301 Demonstrating a differential deficit: Empirical validation of psychometric principles using schizophrenia patients' performance on working memory tasks Becker, T.M.
 2003
 60 1S p. 165-
1 p.
 artikel
302 Depressive symptoms and course identify two distinct clusters within very poor outcome schizophrenia Roy, M.
 2003
 60 1S p. 7-
1 p.
 artikel
303 Dermatoglyphic anomalies and neurological soft signs in twins with schizophrenia Kelly, B.D.
 2003
 60 1S p. 19-
1 p.
 artikel
304 Dermatoglyphics: A comparison of schizophrenia and bipolar disorder McTigue, O.
 2003
 60 1S p. 45-
1 p.
 artikel
305 Determinants of avolition in the daily lives of patients suffering from schizophrenia Delespaul, P.A.
 2003
 60 1S p. 15-
1 p.
 artikel
306 Determining the most efficient referral process for cognitive remediation Lim, R.W.
 2003
 60 1S p. 144-
1 p.
 artikel
307 Developing a first episode psychosis service for an urban population in a large city in Brazil Chaves, A.C.
 2003
 60 1S p. 36-
1 p.
 artikel
308 Developing a healthy lifestyle/fitness programme for people with serious mental illness Winter, K.M.
 2003
 60 1S p. 349-
1 p.
 artikel
309 Developing a job coaching programme for first onset psychosis patients in the Southwark first episode psychosis service (first) Bell, R.
 2003
 60 1S p. 332-
1 p.
 artikel
310 Developing an education resource package to facilitate early detection and optimal treatment: The sooner the better project Crown, M.J.
 2003
 60 1S p. 333-334
2 p.
 artikel
311 Developmental markers in childhood and adolescence and risk for schizophrenia in adult life: A thirty one-year follow-up of the North Finland 1966 birth cohort Isohanni, M.K.
 2003
 60 1S p. 171-172
2 p.
 artikel
312 Diabetes mellitus in patients with schizophrenia is not related to antipsychotic medications Prosperini, P.
 2003
 60 1S p. 365-
1 p.
 artikel
313 Diagnosis and symptom assessment in the schizophrenia prodrome Miller, T.J.
 2003
 60 1S p. 6-7
2 p.
 artikel
314 Diet composition, food preferences and cravings among patients treated with atypical antipsychotics Blouin, M.
 2003
 60 1S p. 352-
1 p.
 artikel
315 Differences in brain activation between control subjects and patients with schizophrenia during mind-wandering: An FMRI study Sherin, J.E.
 2003
 60 1S p. 233-
1 p.
 artikel
316 Different birth-month patterns in autism and schizophrenia Kinney, D.K.
 2003
 60 1S p. 42-
1 p.
 artikel
317 Differential activation of the anterior cingulate and prefrontal cortex in schizophrenic and bipolar patients: An FMRI study Gruber, S.A.
 2003
 60 1S p. 219-
1 p.
 artikel
318 Differential diagnosis of schizophrenia and comorbid schizophrenia and dementia in psychogeriatric inpatients using cognitive screens Bolger, J.P.
 2003
 60 1S p. 125-
1 p.
 artikel
319 Differential effect of 9-OH-risperidone versus risperidone on prolactin elevation: An indicator for drug monitoring? Bruggeman, R.
 2003
 60 1S p. 309-310
2 p.
 artikel
320 Differential effects of haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial learning in rats Terry, A.V.
 2003
 60 1S p. 117-
1 p.
 artikel
321 Differential effects of long-term treatment with clozapine or haloperidol on gaba-transporter expression in adult rat brain Zink, M.
 2003
 60 1S p. 120-
1 p.
 artikel
322 Differential effects of medication status on P50 subcomponent abnormalities in schizophrenia Erwin, R.J.
 2003
 60 1S p. 250-
1 p.
 artikel
323 Differential effects of sustained versus transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats Turrone, P.
 2003
 60 1S p. 368-
1 p.
 artikel
324 Differential rate of weight gain present among patients treated with olanazpine Jaton, L.
 2003
 60 1S p. 357-
1 p.
 artikel
325 Different pattern of cognitive dysfunction in schizophrenia and bipolar affective disorder Krljes, S.
 2003
 60 1S p. 253-254
2 p.
 artikel
326 Diffusion tensor imaging correlates of learning and memory in chronic schizophrenia Nestor, P.G.
 2003
 60 1S p. 150-
1 p.
 artikel
327 DISC-1 (disrupted-in-schizophrenia-1): Its function and possible implication for mental illnesses Sawa, A.
 2003
 60 1S p. 66-
1 p.
 artikel
328 DISC1-immunoreactive cells in the human brain Kirkpatrick, B.
 2003
 60 1S p. 72-
1 p.
 artikel
329 Discrimination of facial expressions in violent and non-violent patients with schizophrenia Weiss, E.M.
 2003
 60 1S p. 161-
1 p.
 artikel
330 Discriminative facility as a predictor of psychological health amongst patients with schizophrenia Wong, A.
 2003
 60 1S p. 331-
1 p.
 artikel
331 Disseminating schizophrenia research findings to patients Mason, S.
 2003
 60 1S p. 340-
1 p.
 artikel
332 Distribution and density of RGS4 MRNA in human postmortem brain sections Lahti, R.A.
 2003
 60 1S p. 100-
1 p.
 artikel
333 Distribution of weight gain in patients taking new generaltion antipsychotics Ball, M.P.
 2003
 60 1S p. 351-
1 p.
 artikel
334 Disturbed self-monitoring of action is correlated with hallucinations and formal thought disorder Stottmeister, F.
 2003
 60 1S p. 26-27
2 p.
 artikel
335 DNA fragmentation is reduced in anterior cingulate cortex of schizophrenics, but not bipolars Benes, F.
 2003
 60 1S p. 60-
1 p.
 artikel
336 DNA stability and schizophrenia in twins Smith, C.L.
 2003
 60 1S p. 96-
1 p.
 artikel
337 Do disrupted sleep processes cause schizophrenia symptoms? A hypothesis Keshavan, M.S.
 2003
 60 1S p. 252-
1 p.
 artikel
338 Does a long-acting atypical antipsychotic offer a low risk of tardive dyskinesia in patients with schizophrenia? Chouinard, G.
 2003
 60 1S p. 277-
1 p.
 artikel
339 Does constant therapy infer optimal efficacy in schizophrenia? Moving to an advanced pharmacotherapeutic option Lasser, R.
 2003
 60 1S p. 291-
1 p.
 artikel
340 Does early onset of parental schizophrenia increase psychopathology in at-risk offspring? Montrose, D.M.
 2003
 60 1S p. 86-
1 p.
 artikel
341 Does synaptic pathology in schizophrenia involve a selective dendritic spine deficit? A study of spinophilin and MAP2 gene expression in the hippocampus Law, A.J.
 2003
 60 1S p. 72-73
2 p.
 artikel
342 Does Toxoplasma gondii cause some cases of schizophrenia? Torrey, E.F.
 2003
 60 1S p. 52-53
2 p.
 artikel
343 Does treatment delay in first-episode psychosis really matter? Harrigan, S.M.
 2003
 60 1S p. 323-
1 p.
 artikel
344 Do family environment and social support predict psychopathology in putative schizotypes? Adams, K.A.
 2003
 60 1S p. 10-
1 p.
 artikel
345 Domians of self-rated quality of life (QOL) in first episode psychosis: Influence of patient and disease characteristics Malla, A.K.
 2003
 60 1S p. 21-
1 p.
 artikel
346 Dopamine depletion and D1 receptor blockade abolish facilitatory effect of clozapine on NMDA- and electrically-evoked responses in pyramidal cells of the rat medial prefrontal cortex Ninan, I.
 2003
 60 1S p. 113-
1 p.
 artikel
347 Dopamine-glutamate interactions in the prefrontal cortex: D1 gating of information processing O'Donnell, P.
 2003
 60 1S p. 257-
1 p.
 artikel
348 Dopamine receptor transcript abnormalities in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depressive disorder Oakman, S.A.
 2003
 60 1S p. 65-66
2 p.
 artikel
349 Do schizophrenia and bipolar disorder belong to the same neurobiological continuum? Neurodeviation in high-risk offspring from birth to adulthood McNeil, T.F.
 2003
 60 1S p. 22-
1 p.
 artikel
350 Do schizotypal factors reflect the associations found between symptom syndromes and cognitive deficits in schizophrenia? McIntosh, L.
 2003
 60 1S p. 146-147
2 p.
 artikel
351 Dose-response analysis of first- and second-generation antipsychotics Davis, J.M.
 2003
 60 1S p. 280-
1 p.
 artikel
352 Do urbanicity and familial liability co-participate in causing psychosis? van Os, J.
 2003
 60 1S p. 53-
1 p.
 artikel
353 Do women really have more bilateral language representation than men? Results from a meta-analysis of functional imaging studies Sommer, I.
 2003
 60 1S p. 233-
1 p.
 artikel
354 DRD3/MSCI molecular genotypes and abnormal involuntary movements in first psychotic episode of patients followed-up one year Apiquian, R.
 2003
 60 1S p. 77-
1 p.
 artikel
355 Drug and alcohol use among patients with schizophrenia and schizoaffective disorder: Levels and consequences Margolese, H.C.
 2003
 60 1S p. 44-
1 p.
 artikel
356 Drug attitudes and treatment adherence in a clinical trial comparing haloperidol and olanzapine in first episode schizophrenia Centorrino, F.
 2003
 60 1S p. 277-
1 p.
 artikel
357 DTI and MTR abnormalities in schizophrenia — Voxel wise analysis of white matter integrity Kubicki, M.
 2003
 60 1S p. 199-
1 p.
 artikel
358 DU127090: A novel partial dopamine agonist with antipsychotic activity a putative potent full spectrum antipsychotic with low EPS potential Arnt, J.
 2003
 60 1S p. 104-
1 p.
 artikel
359 DU127090: A novel partial dopamine agonist with antipsychotic activity behavioral effects of DU127090 in cebus non-human primates Yang, H.
 2003
 60 1S p. 370-
1 p.
 artikel
360 DU 127090: A novel partial dopamine agonist with antipsychotic activity high potency but low efficacy at dopamine D2 receptors in vitro Hesselink, M.B.
 2003
 60 1S p. 108-
1 p.
 artikel
361 DU127090: A novel partial dopamine agonist with antipsychotic activity partial agonist character in functional assays in vivo van Kolfschoten, A.
 2003
 60 1S p. 117-
1 p.
 artikel
362 DU127090: A novel partial dopamine agonist with antipsychotic activity: Pilot study of dopamine D2 receptor occupancy after multiple oral administration of DU127090 to healthy male volunteers, using11C-raclopride by means of positron emission tomography de Vries, M.
 2003
 60 1S p. 239-240
2 p.
 artikel
363 Duration of untreated psychosis, ethnicity and social isolation in the aesop (London) first onset psychosis study Morgan, C.
 2003
 60 1S p. 46-
1 p.
 artikel
364 Dynamic perceptual grouping in schizophrenia: Effects of presentation context and learning Wilkniss, S.M.
 2003
 60 1S p. 185-186
2 p.
 artikel
365 Dysfunctional cognitive coordination in schizophrenia: Evidence from three theoretically motivated tasks Uhlhaas, P.
 2003
 60 1S p. 184-
1 p.
 artikel
366 Dysfunction in temporal order threshold in schizophrenia Braus, D.F.
 2003
 60 1S p. 12-
1 p.
 artikel
367 Early intervention in Hull and East Yorkshire: A comparison of individuals receiving a first episode service with those receiving treatment as usual Macdonald, K.
 2003
 60 1S p. 339-
1 p.
 artikel
368 Early intervention utilising group psychological therapy for auditory hallucinations: A preliminary efficacy trial Newton, E.K.
 2003
 60 1S p. 296-
1 p.
 artikel
369 Ear of stimulation determines schizophrenia-normal brain activity differences in an auditory paired-stimuli paradigm Clementz, B.A.
 2003
 60 1S p. 249-
1 p.
 artikel
370 Economics of persistence with initially prescribed antipsychotic in patients with psychosis or bipolar disorder White, R.E.
 2003
 60 1S p. 348-
1 p.
 artikel
371 Editorial Board 2003
 60 1S p. CO2-
1 p.
 artikel
372 EEG-guided RTMS improves negative symptoms in schizophrenia Jin, Y.
 2003
 60 1S p. 287-288
2 p.
 artikel
373 EEG synchronization and spatial working memory in schizophrenia patients, their unaffected twins, and controls Bachman, P.
 2003
 60 1S p. 248-
1 p.
 artikel
374 Effectiveness of rapid initial dose escalation of oral olanzapine for acute agitation Baker, R.W.
 2003
 60 1S p. 272-
1 p.
 artikel
375 Effectiveness of the integrated psychological therapy (IPT) for schizophrenia patients: A meta-analysis of twenty five years of research Mu¨ller, D.R.
 2003
 60 1S p. 326-
1 p.
 artikel
376 Effect of chronic treatment with neuroleptics on stress responsivity in an animal model for neurodevelopmental psychopathological disorders Terpstra, J.
 2003
 60 1S p. 116-117
2 p.
 artikel
377 Effect of dopamine D1 receptor gene polymorphisms on antipsychotic response in schizophrenia Hwang, R.W.
 2003
 60 1S p. 82-
1 p.
 artikel
378 Effect of glutathione deficit on neurotransmission and synaptic plasticity in rat hippocampus: Relevance for schizophrenia Steullet, P.
 2003
 60 1S p. 261-
1 p.
 artikel
379 Effect of obstetric complications on cognitive function in familial and non-familial schizophrenic probands and their unaffected relatives Kravariti, E.
 2003
 60 1S p. 83-
1 p.
 artikel
380 Effect of quetiapine on cognitive functions in schizophrenia Ky´vy´rcy´k, B.B.
 2003
 60 1S p. 288-
1 p.
 artikel
381 Effect of schizophrenia on frontotemporal activity during word encoding and recognition: An event-related FMRI study Ragland, J.D.
 2003
 60 1S p. 231-
1 p.
 artikel
382 Effect of symptoms on executive function in bipolar illness Dixon, T.
 2003
 60 1S p. 132-
1 p.
 artikel
383 Effect of the selective dopamine D3 receptor antagonist SB-277011 on regional fos expression in the rat forebrain Southam, E.
 2003
 60 1S p. 316-
1 p.
 artikel
384 Effects of a functional COMT polymorphism on neurocognitive function in the 22Q deletion syndrome Bearden, C.E.
 2003
 60 1S p. 78-79
2 p.
 artikel
385 Effects of estrogen augmentation on cognition and symptoms in female schizophrenia patients Hoff, A.L.
 2003
 60 1S p. 139-
1 p.
 artikel
386 Effects of family history and obstetric complications on cognitive functioning at age seven in offspring at high risk for psychosis Seidman, L.J.
 2003
 60 1S p. 157-
1 p.
 artikel
387 Effects of olanzapine versus clozapine on executive functions in schizophrenia Dittmann-Balcar, A.
 2003
 60 1S p. 131-132
2 p.
 artikel
388 Effects of oral ziprasidone and haloperidol on QTC at clinical and high doses Miceli, J.
 2003
 60 1S p. 314-
1 p.
 artikel
389 Effects of postnatal hypoxia on NMDA receptor binding and gene expression of subunits as an animal model for obstetric complications in the pathophysiology of schizophrenia Schmitt, A.
 2003
 60 1S p. 115-
1 p.
 artikel
390 Effects of quetiapine in first episode schizophrenia. Comparison with drug naive patients and healthy controls Jones, H.M.
 2003
 60 1S p. 224-225
2 p.
 artikel
391 Effects of risperidone and zuclopenthixol on cognitive deficits in drug-naive first episode schizophrenic patients Fagerlund, B.
 2003
 60 1S p. 133-134
2 p.
 artikel
392 Effects of smoking and nicotine nasal spray on cognition and affect in schizophrenia Smith, R.C.
 2003
 60 1S p. 316-
1 p.
 artikel
393 Effects of treatment with antipsychotic medication on cigarette smoking in patients with early schizophrenia and minimal previous antipsychotic exposure Lenroot, R.
 2003
 60 1S p. 292-
1 p.
 artikel
394 Effects of typical and atypical antipsychotic drugs on monoaminergic neurotransmission in the rat nucleus accumbens and medial prefrontal cortex Shilliam, C.S.
 2003
 60 1S p. 115-
1 p.
 artikel
395 Effects of typical and atypical antipsychotics on maternal behavior in postpartum female rats Budin, R.
 2003
 60 1S p. 104-
1 p.
 artikel
396 Effects of typical and atypical antipsychotic treatment on antisaccade and prosaccade eye movements in schizophrenia Ettinger, U.
 2003
 60 1S p. 265-266
2 p.
 artikel
397 Effects on weight change of switching from olanzapine to quetiapine Masand, P.
 2003
 60 1S p. 362-
1 p.
 artikel
398 Efficacy and safety of olanzapine, risperidone and haloperidol in acute treatment of patients with first episode psychosis Perez, R.
 2003
 60 1S p. 298-299
2 p.
 artikel
399 Efficacy and safety of quetiapine in borderline personality disorder Adityanjee, A.
 2003
 60 1S p. 270-
1 p.
 artikel
400 Efficacy and safety of quetiapine in the treatment of patients with schizophrenia in Korea Lee, H.
 2003
 60 1S p. 291-292
2 p.
 artikel
401 Efficacy and tolerability of switching antipsychotic therapy with ziprasidone in the correctional setting: A pilot project Pondrom, M.
 2003
 60 1S p. 299-
1 p.
 artikel
402 Electron microscopic localization of Reelin in the adult human cortex: A postmortem ultrastructural study Roberts, R.C.
 2003
 60 1S p. 74-
1 p.
 artikel
403 Elements of the stress cascade and the neurobiology of schizophrenia Corcoran, C.
 2003
 60 1S p. 13-
1 p.
 artikel
404 Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring Babulas, V.
 2003
 60 1S p. 33-
1 p.
 artikel
405 Emotional impairments in the patients with schizophrenia An, S.
 2003
 60 1S p. 163-
1 p.
 artikel
406 Emotional memory, the amygdala and the basis of mood congruent delusions Gibbs, A.
 2003
 60 1S p. 195-
1 p.
 artikel
407 Emotional processing in schizophrenia: Subjective ratings to evocative visual stimuli Fleming, K.
 2003
 60 1S p. 134-
1 p.
 artikel
408 Emotion recognition deficits and cognition in schizophrenia Sachs, G.
 2003
 60 1S p. 181-182
2 p.
 artikel
409 Enduring positive symptoms in first episode psychosis: A randomised controlled trial of clozapine and CBT Edwards, J.
 2003
 60 1S p. 321-
1 p.
 artikel
410 Enhanced hippocampal-mediated HPA response to stress in schizophrenia Goldman, M.
 2003
 60 1S p. 99-
1 p.
 artikel
411 Enhanced vividness of mental imagery as a trait marker of schizophrenia? Linden, D.E.
 2003
 60 1S p. 20-
1 p.
 artikel
412 Enhancing goal-directed behavior in schizophrenia Heinssen, R.
 2003
 60 1S p. 323-324
2 p.
 artikel
413 Entorhinal cortex, schizophrenia and its symptoms: A structural MRI study Prasad, K.M.
 2003
 60 1S p. 205-206
2 p.
 artikel
414 EPOS — General outlines of the “European prediction of psychosis study” Klosterko¨tter, J.
 2003
 60 1S p. 5-
1 p.
 artikel
415 ERP abnormalities in schizophrenia and the theory of loss of rapidly conducting axons Miller, R.
 2003
 60 1S p. 255-256
2 p.
 artikel
416 Errorless learning in patients with schizophrenia and non-affected controls Wood, A.E.
 2003
 60 1S p. 186-
1 p.
 artikel
417 Estimating the proportion of schizophrenia patients for whom QTC prolonging antipsychotics may be contraindicated McCollam, P.
 2003
 60 1S p. 362-363
2 p.
 artikel
418 Estrogen treatment in women with schizophrenia: Psychotic symptom and cognitive response Kulkarni, J.
 2003
 60 1S p. 291-
1 p.
 artikel
419 Ethnic differences in outpatient novel antipsychotic use in the United States Daumit, G.L.
 2003
 60 1S p. 334-335
2 p.
 artikel
420 Ethnicity and antipsychotic prescribing review Wheeler, A.
 2003
 60 1S p. 347-348
2 p.
 artikel
421 Ethnic/racial comparisons in symptomatology in a large sample of patients with schizophrenia in Texas Dassori, A.M.
 2003
 60 1S p. 14-
1 p.
 artikel
422 Evaluation of a novel schizophrenia model made by neonatal neurotrophic perturbation Nawa, H.
 2003
 60 1S p. 113-
1 p.
 artikel
423 Evaluation of mood symptoms in schizophrenia using POMS (profile of mood state): Retrospective analysis Sheikh, S.
 2003
 60 1S p. 8-
1 p.
 artikel
424 Evaluation of NOTCH4 polymorphisms in schizophrenia using family-based association Klempan, T.A.
 2003
 60 1S p. 82-83
2 p.
 artikel
425 Evaluation of the efficacy of 20mg olanzapine in the treatment of acute psychosis in an emergency psychiatric department Ballerini, A.C.
 2003
 60 1S p. 272-
1 p.
 artikel
426 Evidence for a common etiology of perceptual, motor, and linguistic disorganization in schizophrenia Silverstein, S.M.
 2003
 60 1S p. 183-
1 p.
 artikel
427 Evidence for a role of endogenous cannabinoids in schizophrenia Leweke, F.
 2003
 60 1S p. 101-
1 p.
 artikel
428 Evidence for normal cortical inhibition in first-degree relatives of schizophrenic patients: A preliminary report Saka, M.C.
 2003
 60 1S p. 259-
1 p.
 artikel
429 Evidence of oculomotor and skeletomotor deficits in psychometric schizotypy Holahan, A.V.
 2003
 60 1S p. 266-
1 p.
 artikel
430 Evidence of predictive smooth pursuit eye movement deficits in schizophrenia using a newly developed cued target paradigm Avila, M.T.
 2003
 60 1S p. 265-
1 p.
 artikel
431 Evidence of semantic disorganisation in schizophrenia using a new word definition task Rossell, S.L.
 2003
 60 1S p. 181-
1 p.
 artikel
432 Evidence that social environments modify the expression of psychosis vulnerability in daily life Verdoux, H.
 2003
 60 1S p. 53-54
2 p.
 artikel
433 Excess mortality in schizophrenia in Stockholm County, Sweden O¨sby, U.
 2003
 60 1S p. 48-
1 p.
 artikel
434 Experiences of patients with antipsychotic medication: A questionnaire Wolters, H.A.
 2003
 60 1S p. 370-
1 p.
 artikel
435 Experience with atypical antipsychotics in an acute inpatient unit Keks, N.A.
 2003
 60 1S p. 289-
1 p.
 artikel
436 Explaining variation in the premorbid adjustment of schizophrenia patients: The role of season of birth and family history St-Hilaire, A.
 2003
 60 1S p. 26-
1 p.
 artikel
437 Exploration of a causal link between atypical antipsychotic usage and new onset diabetes mellitus: A review of the scientific evidence Toalson, P.
 2003
 60 1S p. 367-368
2 p.
 artikel
438 Exploring the neurochemical basis for the cognitive effects of atypical antipsychotics Tyson, P.J.
 2003
 60 1S p. 160-
1 p.
 artikel
439 Expression of the NR3A subunit of the NMDA receptor in human brain Mueller, H.T.
 2003
 60 1S p. 65-
1 p.
 artikel
440 Expression of vesicular glutamate transporters one and two in medial temporal lobe structures in schizophrenia, bipolar disorder, and major depressive disorder McCullumsmith, R.E.
 2003
 60 1S p. 65-
1 p.
 artikel
441 Extensive glial cytoarchitecture visualised in frontal cortex: Role in psychosis Toro, C.T.
 2003
 60 1S p. 75-76
2 p.
 artikel
442 Extralimital triradii as a marker of risk for schizotypy Chok, J.T.
 2003
 60 1S p. 13-
1 p.
 artikel
443 Ex-vivo autoradiography: A crucial tool for developing potential therapeutic agents for the treatment of schizophrenia Langlois, X.
 2003
 60 1S p. 110-
1 p.
 artikel
444 Face recognition memory deficits in schizophrenia patients and their relatives: Comparison with visual object memory performance Calkins, M.E.
 2003
 60 1S p. 128-
1 p.
 artikel
445 Factors associated with inpatient aggression and early re-admission to acute psychiatry units Lewin, T.J.
 2003
 60 1S p. 338-
1 p.
 artikel
446 Failure of prefrontal habituation to novelty in schizophrenia: An event-related FMRI study Gur, R.E.
 2003
 60 1S p. 219-
1 p.
 artikel
447 Family caregivers of people with first-episode psychosis: Rewards of caregiving Tennakoon, L.
 2003
 60 1S p. 346-
1 p.
 artikel
448 Fasting plasma lipids, glucose and insulin, and C-reactive protein are related to adiposity in schizophrenia Newcomer, J.W.
 2003
 60 1S p. 363-
1 p.
 artikel
449 Fatty acid metabolism in schizophrenia: Comparison of the effects of prolizin and clozapine Waldo, M.C.
 2003
 60 1S p. 317-
1 p.
 artikel
450 Febrile seizures and schizophrenia — A population-based cohort study Vestergaard, M.
 2003
 60 1S p. 54-
1 p.
 artikel
451 Fighting stigma and discrimination because of schizophrenia Sartorius, N.
 2003
 60 1S p. 344-
1 p.
 artikel
452 Findings from a naturalistic drug utilization observation phase IV study: Subjective well-being, quality of life, and global functioning in schizophrenic patients treated with olanzapine Linden, M.
 2003
 60 1S p. 339-
1 p.
 artikel
453 First-episode psychosis: A comparative study of patients with short versus long duration of untreated illness Koehn, D.
 2003
 60 1S p. 19-
1 p.
 artikel
454 First-episode schizophrenia: A follow-up study on neurological soft signs Bachmann, S.
 2003
 60 1S p. 10-
1 p.
 artikel
455 Flanker effect in schizophrenia Turner, B.
 2003
 60 1S p. 160-
1 p.
 artikel
456 Fluoxetine augmentation of haloperidol in chronic schizophrenia Shim, J.
 2003
 60 1S p. 303-
1 p.
 artikel
457 FMRI of smooth pursuit eye movement abnormalities in schizophrenia Tregellas, J.
 2003
 60 1S p. 235-
1 p.
 artikel
458 FMRI study of motor circuit dysfunction in schizophrenia Caligiuri, M.P.
 2003
 60 1S p. 213-214
2 p.
 artikel
459 Formal thought disorder: What mechanisms are involved when schizophrenics says and think strange things Harrow, M.
 2003
 60 1S p. 170-
1 p.
 artikel
460 Fractal analysis of magnetic resonance images(MRI): A comparative study of schizophrenia and obsessive-compulsive disorder Ha, T.
 2003
 60 1S p. 196-197
2 p.
 artikel
461 Frontal and thalamic hypometabolism in schizophrenia Cullen, T.
 2003
 60 1S p. 216-
1 p.
 artikel
462 Frontal brain NAA T2 values are significantly lower in schizophrenia Ke, Y.
 2003
 60 1S p. 242-
1 p.
 artikel
463 Frontal lobe functioning, psychiatric symptoms, and quality of life in outpatients with schizophrenia Kennedy, A.
 2003
 60 1S p. 141-
1 p.
 artikel
464 Frontonasal-maxillary dysmorphology in schizophrenia: Palatal midline anomalies among probands and their relatives Saunders, E.
 2003
 60 1S p. 90-
1 p.
 artikel
465 Functional cerebral deficits during cognitive performance in first-episode schizophrenia patients: A multi-center FMRI study Klein, M.
 2003
 60 1S p. 225-226
2 p.
 artikel
466 Functional connectivity of inner speech in schizophrenia Kanaan, R.A.
 2003
 60 1S p. 225-
1 p.
 artikel
467 Functional imaging in subjects at high risk of schizophrenia Whalley, H.C.
 2003
 60 1S p. 237-
1 p.
 artikel
468 Functional MRI assessment of atypical and conventional antipsychotic effects on cognitive function in schizophrenia patients Morey, R.A.
 2003
 60 1S p. 229-
1 p.
 artikel
469 Functional MRI at 3t during a go/no-go performance in patients with schizophrenia Hoptman, M.J.
 2003
 60 1S p. 222-223
2 p.
 artikel
470 Functional neuroanatomy of auditory sensory memory Johnston, P.
 2003
 60 1S p. 224-
1 p.
 artikel
471 Further evidence for association of promoter variants in human alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia Logel, J.
 2003
 60 1S p. 95-
1 p.
 artikel
472 Galantamine benefits in Alzheimer's disease are related to increases in dopamine output Geerts, H.
 2003
 60 1S p. 135-
1 p.
 artikel
473 Gamma band activity during a degraded-stimulus continuous performance task in schizophrenia patients and their first-degree biological relatives Sponheim, S.R.
 2003
 60 1S p. 260-
1 p.
 artikel
474 GAP-43 and synaptophysin immunostaining reveal subtle alterations in neural circuitry in the dentate gyrus of patients with schizophrenia Chambers, J.S.
 2003
 60 1S p. 69-
1 p.
 artikel
475 Gender differences in response to a weight management intervention are not upheld up to twelve months Ohlsen, R.I.
 2003
 60 1S p. 364-
1 p.
 artikel
476 Gender differences in schizophrenia: Results from the schizophrenia outpatient health outcomes study (SOHO) Haro, J.M.
 2003
 60 1S p. 285-
1 p.
 artikel
477 Gender effects in prepulse inhibition and facilitation deficits in schizophrenia Kumari, V.
 2003
 60 1S p. 254-
1 p.
 artikel
478 Gender related differences in acute schizophrenia Olgiati, P.
 2003
 60 1S p. 48-
1 p.
 artikel
479 Gene expression in schizophrenia and bipolar disorder Bahn, S.
 2003
 60 1S p. 60-
1 p.
 artikel
480 General and specific cognitive deficits in schizophrenia Dickinson, D.
 2003
 60 1S p. 131-
1 p.
 artikel
481 Generalized deficits in social skills in some, but not all, patients with schizophrenia Bellack, A.S.
 2003
 60 1S p. 11-
1 p.
 artikel
482 Genetics of symptom severity and response to treatment in first-episode schizophrenia: Association with 5-HT2C, D3 and D2 polymorphisms Reynolds, G.P.
 2003
 60 1S p. 89-
1 p.
 artikel
483 Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia Zai, G.C.
 2003
 60 1S p. 97-
1 p.
 artikel
484 Genetic vasopressin deficiency facilitates performance of a lateralized reaction time task: Altered attentional and motor processes Jentsch, J.
 2003
 60 1S p. 108-
1 p.
 artikel
485 GJB5, selected by differential screening of gene initiation sequences, is associated with schizophrenia Ni, X.
 2003
 60 1S p. 88-
1 p.
 artikel
486 Glial fibrillary acidic protein is reduced in cerebellum of subjects with mood disorders and schizophrenia Fatemi, S.H.
 2003
 60 1S p. 61-62
2 p.
 artikel
487 Globus pallidus volume is related to cognitive performance in healthy controls but not in patients with schizophrenia Spinks, R.
 2003
 60 1S p. 207-
1 p.
 artikel
488 Glucose and lipid metabolism in patients treated with atypical and conventional antipsychotic medication Lindenmayer, J.
 2003
 60 1S p. 361-
1 p.
 artikel
489 Glutamate receptor gene (GRIN1, GRIN2B) in schizophrenia: TDT and case-controls analyses Martucci, L.
 2003
 60 1S p. 85-
1 p.
 artikel
490 Glutamate receptor subunits are altered in frontal cortex and cerebellum in a rat model of schizophrenia Lindahl, J.S.
 2003
 60 1S p. 73-
1 p.
 artikel
491 Gray and white matter volume abnormalities in monozygotic and same-sex dizygotic twins discordant for schizophrenia Pol, H. Hulshoff
 2003
 60 1S p. 198-
1 p.
 artikel
492 Gray matter-abnormalities and clinical symptoms in patients with schizophrenia using a voxel based morphometry Kwon, J.
 2003
 60 1S p. 200-
1 p.
 artikel
493 Gray matter changes in the early course of schizophrenia Diwadkar, V.A.
 2003
 60 1S p. 193-
1 p.
 artikel
494 Grey and white matter changes in the aesop first-onset psychosis study: A voxel-based analysis of brain structure Dazzan, P.
 2003
 60 1S p. 192-
1 p.
 artikel
495 Grey and white matter deficits in males with chronic schizophrenia: An automated MR image analysis Soulsby, B.
 2003
 60 1S p. 206-207
2 p.
 artikel
496 Group CBT versus group symptom management for treating psychotic symptoms of young individuals presenting with a first episode of schizophrenia — Preliminary results Lecomte, T.
 2003
 60 1S p. 324-325
2 p.
 artikel
497 Group cognitive behavioral therapy (CBT) for first episode clients: Description of the therapy Leclerc, C.
 2003
 60 1S p. 324-
1 p.
 artikel
498 Group II selective MGLU receptor agonists block ketamine-evoked glutamate release in the rat prefrontal cortex and hippocampus Lorrain, D.S.
 2003
 60 1S p. 111-112
2 p.
 artikel
499 Guidelines adherence in treated schizophrenic patients Fernandez, I.
 2003
 60 1S p. 283-
1 p.
 artikel
500 Hallucinatory experiences and onset of psychotic disorder: The role of cognitive appraisals Krabbendam, L.
 2003
 60 1S p. 42-
1 p.
 artikel
501 Harm avoidance and schizotypal traits in a sample of severe juvenile delinquents Servais, L.
 2003
 60 1S p. 7-8
2 p.
 artikel
502 Has medication adherence improved with the new-generation atypical antipsychotics? Maples, N.J.
 2003
 60 1S p. 325-
1 p.
 artikel
503 Have you suffered vexation, grief or reverse of fortune? Smith, D.J.
 2003
 60 1S p. 9-
1 p.
 artikel
504 Health and development in the first four years of life in offspring of women with different psychoses: Well-baby clinic information Henriksson, K.M.
 2003
 60 1S p. 138-
1 p.
 artikel
505 Heart rate variability in medication-free patients with schizophrenia may provide clues towards understanding limbic dysregulation in psychosis Mujica-Parodi, L.R.
 2003
 60 1S p. 256-
1 p.
 artikel
506 Hedonic judgments and relative food and odor preferences as probes of prefrontal cortex function and anhedonia in schizophrenia Folley, B.S.
 2003
 60 1S p. 134-
1 p.
 artikel
507 Helping persons with schizophrenia stay employed: Challenges to implementing the workplace fundamentals module in the clinic Okeefe, C.
 2003
 60 1S p. 327-
1 p.
 artikel
508 Hemispheric asymmetry of the superior temporal cortex in postmortem schizophrenic and control brains Smiley, J.F.
 2003
 60 1S p. 75-
1 p.
 artikel
509 Heterogeneity of schizophrenia: A genetic association study of variation in cognitive function and chromosome 13 markers Pogue-Geile, M.F.
 2003
 60 1S p. 89-
1 p.
 artikel
510 High body mass index in mothers at early pregnancy and low birthweight in schizophrenia Takagai, S.
 2003
 60 1S p. 52-
1 p.
 artikel
511 High dose PCP in rat PUP alters adult rat behavior Gao, X.M.
 2003
 60 1S p. 106-
1 p.
 artikel
512 High dose quetiapine in treatment refractory schizophrenia Pierre, J.M.
 2003
 60 1S p. 299-
1 p.
 artikel
513 Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: A historical-prospective cohor study Weiser, M.
 2003
 60 1S p. 55-
1 p.
 artikel
514 High field MRS of glutamate and schizophrenia Schulz, S.C.
 2003
 60 1S p. 245-246
2 p.
 artikel
515 High maternal body mass index in pregnancy as a risk factor for schizophrenia in offspring Kawai, M.
 2003
 60 1S p. 40-41
2 p.
 artikel
516 Hippocampal volumes analysis on magnetic resonance images in schizophrenic and non affected family members — genetic loading and impact of obstetric complications Tepest, R.
 2003
 60 1S p. 209-
1 p.
 artikel
517 Hippocampal volumes in schizophrenic twins van Erp, T.G.
 2003
 60 1S p. 210-
1 p.
 artikel
518 Histone-profiling in prefrontal cortex of schizophrenics and controls Akbarian, S.
 2003
 60 1S p. 68-
1 p.
 artikel
519 How are cognitive symptoms and social skills in schizophrenia related? Bentsen, H.
 2003
 60 1S p. 11-12
2 p.
 artikel
520 How far is psychopathology still meaningful for early detection of schizophrenia? Lanzaro, M.
 2003
 60 1S p. 5-
1 p.
 artikel
521 How psychotic are individuals with non-psychotic disorders? Hanssen, M.S.
 2003
 60 1S p. 17-
1 p.
 artikel
522 How useful are learning potential assessments in predicting rehabilitation outcome in schizophrenia? Sergi, M.J.
 2003
 60 1S p. 328-
1 p.
 artikel
523 HPA-axis functioning and the onset of psychosis in a high-risk group: Preliminary investigations Phillips, L.
 2003
 60 1S p. 48-
1 p.
 artikel
524 HSV-1 serology predicts cognitive deficits in bipolar disorder similar to schizophrenia Boronow, J.J.
 2003
 60 1S p. 125-126
2 p.
 artikel
525 5HT2A and muscarinic receptors in schizophrenia: A post-mortem study Inoue, Y.
 2003
 60 1S p. 63-64
2 p.
 artikel
526 5-HT2A antagonism does not affect catalepsy in rats Hicks, P.B.
 2003
 60 1S p. 356-357
2 p.
 artikel
527 Humour perception deficits in schizophrenia Polimeni, J.
 2003
 60 1S p. 178-
1 p.
 artikel
528 Hyperprolactinemia is uncoupled from D2/D3 dopamine receptor occupancy in long-term amisulpride treated patients Bressan, R.A.
 2003
 60 1S p. 239-
1 p.
 artikel
529 ICV injections of antisense oligonucleotides for the α7 nicotinic receptor reduce auditory gating in sprague-Dawley rats Stevens, K.
 2003
 60 1S p. 261-
1 p.
 artikel
530 Identification of synapse-associated protein 90/postsynaptic density-95-associated protein (SAPAP) in the nucleus accumbens of phencyclidine-treated rats using differential display and alteration in the nucleus accumbens of patients with schizophrenia Shirakawa, O.
 2003
 60 1S p. 115-
1 p.
 artikel
531 Identifying task-related neural abnormalities present in first episode and chronic schizophrenia O'Ceallaigh, S.
 2003
 60 1S p. 230-
1 p.
 artikel
532 Illness severity, patient impression of treatment and side effect profile in a sample of young psychotic adults treated with either risperidone or olanzapine Villeneuve, J.
 2003
 60 1S p. 369-
1 p.
 artikel
533 Impact of genetic vulnerability, pre and perinatal complications and sex on seven-year outcomes in offspring high risk for psychosis Goldstein, J.M.
 2003
 60 1S p. 39-
1 p.
 artikel
534 Impact of nicotine on brain function in smokers with schizophrenia Jacobsen, L.K.
 2003
 60 1S p. 223-224
2 p.
 artikel
535 Impact of present and past antipsychotic side-effects on attitude toward typical antipsychotic treatment and compliance Lambert, M.
 2003
 60 1S p. 360-
1 p.
 artikel
536 Impaired hippocampal-mediated glucocorticoid negative feedback in schizophrenia Hussain, N.
 2003
 60 1S p. 99-100
2 p.
 artikel
537 Impaired niacin flushing in schizophrenia: Possible biochemical mechanisms Bennett, C.N.
 2003
 60 1S p. 98-
1 p.
 artikel
538 Impaired prepulse inhibition of the startle reflex in patients with prodromal symptoms of schizophrenia Koev, I.
 2003
 60 1S p. 253-
1 p.
 artikel
539 Impaired recognition of biological motion in schizophrenia Kim, J.
 2003
 60 1S p. 141-
1 p.
 artikel
540 Improved attention is associated with reductions in frontal lobe lactate levels in first episode psychosis Yurgelun-Todd, D.A.
 2003
 60 1S p. 318-
1 p.
 artikel
541 Improving decisional capacity for informed consent in schizophrenia Prentice, K.J.
 2003
 60 1S p. 327-328
2 p.
 artikel
542 Impulsivity and aggression in 22Q11 deletion syndrome and schizophrenia Chow, E.W.
 2003
 60 1S p. 79-
1 p.
 artikel
543 Incipient neurovulnerability and neuroprotection in early psychosis: A proton spectroscopy study of the anterior hippocampus at 3Tesla Berger, G.E.
 2003
 60 1S p. 238-
1 p.
 artikel
544 Increased amphetamine-induced dopamine release during experimental sensitization to psychostimulants: A PET/11C-raclopride study in healthy volunteers Boileau, I.
 2003
 60 1S p. 238-239
2 p.
 artikel
545 Increased expression of normal prion protein (PRPC) in schizophrenia and bipolar disorder Weis, S.
 2003
 60 1S p. 76-
1 p.
 artikel
546 Increased hippocampal neurogenesis accompanies apoptosis in neonatal rats exposed to intracerebroventricular kainic acid Dong, H.
 2003
 60 1S p. 56-
1 p.
 artikel
547 Increased risk for schizophrenia in siblings of patients with schizotypal personality disorder Caspi, A.
 2003
 60 1S p. 36-
1 p.
 artikel
548 Indirect semantic priming in schizophrenic patients Chiu, C.
 2003
 60 1S p. 129-
1 p.
 artikel
549 Inflammatory cytokines and features of the metabolic syndrome among patients treated with atypical antipsychotics Alme´ras, N.
 2003
 60 1S p. 350-
1 p.
 artikel
550 Inhibition of psychostimulant-induced hyperactivity responses in rats following oral administration of the metabotropic glutamate receptor 2/3 agonists, LY379268 and MGS0028 Campbell, U.C.
 2003
 60 1S p. 104-105
2 p.
 artikel
551 Initial treatment of acutely exacerbated and highly agitated schizophrenic patients with risperidone Pajonk, F.G.
 2003
 60 1S p. 298-
1 p.
 artikel
552 Initiation of olanzapine or risperidone: Effects on health outcomes among patients with schizophrenia Ren, X.S.
 2003
 60 1S p. 342-343
2 p.
 artikel
553 Innovative methods for extracting valid cognitive deficit profiles from NP test data in schizophrenia Jaeger, J.
 2003
 60 1S p. 140-
1 p.
 artikel
554 Insight in first-episode schizophrenia: A metacognitive neuropsychological study Koren, D.
 2003
 60 1S p. 173-174
2 p.
 artikel
555 Insight in psychosis and neuropsychological function: A meta-analysis Agrawal, N.
 2003
 60 1S p. 121-
1 p.
 artikel
556 Insight: Unitary or multi-dimensional phenomenon? David, A.S.
 2003
 60 1S p. 14-
1 p.
 artikel
557 Integration, differentiation, delusion in schizophrenia Lee, K.
 2003
 60 1S p. 174-
1 p.
 artikel
558 Integration of a token economy program with psychosocial and psychopharmacological research on a treatment refractory schizophrenia unit Tenhula, W.N.
 2003
 60 1S p. 329-330
2 p.
 artikel
559 International congress on schizophrenia research Tamminga, Carol A.
 2003
 60 1S p. 1-
1 p.
 artikel
560 Interpersonal problem solving skills and electrodermal activity in schizophrenia Hultman, C.
 2003
 60 1S p. 251-252
2 p.
 artikel
561 In utero exposure to a 7.9 (richter) earthquake and adult schizotypal personality Macho´n, R.A.
 2003
 60 1S p. 43-44
2 p.
 artikel
562 Investigation of olanzapine-associated weight gain in first episode subjects Graham, K.A.
 2003
 60 1S p. 355-356
2 p.
 artikel
563 In vivo visualization of corpus callosum abnormalities in schizophrenia Goghari, V.M.
 2003
 60 1S p. 196-
1 p.
 artikel
564 Ionotropic glutamate receptor expression in prefrontal and cingulate cortex in schizophrenia, bipolar disorder, and major depression Beneyto, M.
 2003
 60 1S p. 60-
1 p.
 artikel
565 Is first best? A preliminary study of the effectiveness of the southwark first episode psychosis team (first) versus standard care Walters, J.T.
 2003
 60 1S p. 331-
1 p.
 artikel
566 Is it possible to reduce the duration of untreated psychosis? Melle, I.
 2003
 60 1S p. 45-
1 p.
 artikel
567 Is it worth treating mentally ill roofless people? Girgis, S.
 2003
 60 1S p. 284-285
2 p.
 artikel
568 Is the brain derived neurotrophic factor gene a common risk factor for schizophrenia and bipolar disorder? Muglia, P.
 2003
 60 1S p. 87-
1 p.
 artikel
569 Is the heterozygous reeler mouse an animal model of schizophrenia?: A comprehensive study of dopamine function Minabe, Y.
 2003
 60 1S p. 112-
1 p.
 artikel
570 Is there an association between subsyndromal psychotic states and neurodevelopmental markers of schizophrenia in the general population? Lloyd, T.
 2003
 60 1S p. 43-
1 p.
 artikel
571 Keyword index 2003
 60 1S p. 393-401
9 p.
 artikel
572 ‘K’ is for ketamine: An FMRI study of the neural correlates of a ketamine-induced psychotic state on word generation Fu, C.
 2003
 60 1S p. 218-
1 p.
 artikel
573 Lack of insight in schizophrenia is not a dysexecutive phenomenon Boos, H.
 2003
 60 1S p. 125-
1 p.
 artikel
574 Lack of right hemispheric activation during word encoding in schizophrenic patients: An FMRI study Leube, D.T.
 2003
 60 1S p. 227-
1 p.
 artikel
575 Languages system abnormalities in patients with schizophrenia: Syntactic deficits are related to prefrontal function, thought disorder, and abnormal movement Weickert, T.W.
 2003
 60 1S p. 185-
1 p.
 artikel
576 Latent inhibition in first episode of schizophrenia Rascle, C.S.
 2003
 60 1S p. 179-
1 p.
 artikel
577 Lateral cortical interactions in schizophrenia: A visual evoked potential study Kim, D.
 2003
 60 1S p. 252-
1 p.
 artikel
578 Life experiences of elderly people with schizophrenia: A qualitative report Lambert, S.
 2003
 60 1S p. 19-
1 p.
 artikel
579 Limbic cortical D2 dopamine receptor occupancy by antipsychotic drugs-resolving conflicting findings Erlandsson, K.
 2003
 60 1S p. 240-
1 p.
 artikel
580 Linkage analysis in schizophrenia using a neurocognitive phenotype Jablensky, A.V.
 2003
 60 1S p. 94-
1 p.
 artikel
581 Long-acting injectable risperidone: Safety and efficacy in patients switched from conventional depot antipsychotics Turner, M.
 2003
 60 1S p. 305-
1 p.
 artikel
582 Long-acting risperidone: Prolonged-release injectable delivery of risperidone using medisorbò microsphere technology Ramstack, M.
 2003
 60 1S p. 314-
1 p.
 artikel
583 Longitudinal effect of olanzapine on fasting serum lipids: A randomized, prospective, four-month study Kinon, B.J.
 2003
 60 1S p. 358-
1 p.
 artikel
584 Long-term effects of treatment on quality of life in schizophrenia patients: A comparison between WHOQoL and EuroQoL (EQ-5D) Vande Willige, G.
 2003
 60 1S p. 346-347
2 p.
 artikel
585 Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia McEvoy, J.
 2003
 60 1S p. 313-
1 p.
 artikel
586 Low blood selenium concentrations in schizophrenic patients treated with clozapine: A risk factor for myocarditis and cardiomyopathy? Vaddadi, K.
 2003
 60 1S p. 368-369
2 p.
 artikel
587 Low glycogen synthase kinase-3β in schizophrenia — Genetic marker or consequence of neurodevelopmental insult Kozlovsky, N.
 2003
 60 1S p. 64-
1 p.
 artikel
588 Low proarrhythmic potential of the antipsychotic sertindole in animal models of torsade de pointes Haverkamp, W.
 2003
 60 1S p. 356-
1 p.
 artikel
589 Male adolescents with affective disorders are at increased risk of later hospitalization for schizophrenia: A historical-prospective cohort study Davidson, M.
 2003
 60 1S p. 37-
1 p.
 artikel
590 Mapping the onset of psychosis: The comprehensive assessment of at risk mental states (CAARMS) Yung, A.R.
 2003
 60 1S p. 30-31
2 p.
 artikel
591 Maternal exposure to herpes simplex virus type 2 and psychosis among adult offspring: Replication and specificity Buka, S.L.
 2003
 60 1S p. 35-
1 p.
 artikel
592 Maternal influenza and schizophrenia: A cohort study Watson, J.B.
 2003
 60 1S p. 55-
1 p.
 artikel
593 Measuring prepulse inhibition and facilitation of the eyeblink response to acoustic startle during continuous acquisition with ER-FMRI Chien, A.S.
 2003
 60 1S p. 214-215
2 p.
 artikel
594 Mechanism of action of quetiapine: A modulator of dopamine at the D2 receptor Goldstein, J.M.
 2003
 60 1S p. 311-
1 p.
 artikel
595 Medial temporal lobe activation and memory in schizophrenia following glucose ingestion: An FMRI study Stone, W.S.
 2003
 60 1S p. 234-
1 p.
 artikel
596 Medication strategies in first onset schizophrenia: A randomized trial of effectiveness of short versus sustained antipsychotic treatment and quality of life in first episode psychosis preliminary findings: Incidence, compliance and early course Wunderink, L.
 2003
 60 1S p. 307-
1 p.
 artikel
597 Melbourne high risk study: Olfactory identification ability is impaired in individuals at ultra high-risk for psychosis who later develop schizophrenia Brewer, W.J.
 2003
 60 1S p. 126-
1 p.
 artikel
598 Memory performance at onset may be predictive of the course of schizophrenia Nieman, D.
 2003
 60 1S p. 151-
1 p.
 artikel
599 Memory strategy deficits in schizophrenia Bryan, J.
 2003
 60 1S p. 127-
1 p.
 artikel
600 Mesifos: Medication strategies in first onset schizophrenia effects of short versus sustained antipsychotic treatment on quality of life after first episode psychosis: A randomized trial Nienhuis, F.
 2003
 60 1S p. 296-297
2 p.
 artikel
601 Meta-analysis fails to reveal evidence of activation hypofrontality in schizophrenia Hill, K.E.
 2003
 60 1S p. 221-
1 p.
 artikel
602 Meta-analysis of cardiac safety with aripiprazole Kostic, D.
 2003
 60 1S p. 359-
1 p.
 artikel
603 Meta-analysis of neurocognitive deficits in relatives of patients with schizophrenia: Evidence for a strong cognitive endophenotypic marker Sitskoorn, M.
 2003
 60 1S p. 90-
1 p.
 artikel
604 Meta-analysis of P50 research in schizophrenia de Wilde, O.M.
 2003
 60 1S p. 249-
1 p.
 artikel
605 Meta-analysis of prolactin effects with aripiprazole Abou-Gharbia, N.
 2003
 60 1S p. 350-
1 p.
 artikel
606 Meta-analysis of semantic priming in schizophrenia Oh, T.M.
 2003
 60 1S p. 177-
1 p.
 artikel
607 Meta-analysis of the efficacy of aripiprazole in schizophrenia Carson, W.H.
 2003
 60 1S p. 276-
1 p.
 artikel
608 Meta-analysis of weight effects with aripiprazole Jody, D.
 2003
 60 1S p. 358-
1 p.
 artikel
609 Metabolite alterations in the basal ganglia associated with methamphetamine-related psychiatric symptoms: A proton MRS study Sekine, Y.
 2003
 60 1S p. 246-
1 p.
 artikel
610 Microstructural white matter changes as correlates of impaired frontal task performance in first episode schizophrenia Carbon, M.
 2003
 60 1S p. 191-
1 p.
 artikel
611 Mismatch negativity amplitude and heschl's gyrus volume in first-episode schizophrenia Salisbury, D.F.
 2003
 60 1S p. 259-
1 p.
 artikel
612 Mismatch negativity and behavioral indices of auditory temporal processing in schizophrenia Davalos, D.
 2003
 60 1S p. 249-250
2 p.
 artikel
613 Mismatch negativity: Evidence for an NMDA-based disorder of brain plasticity in the temporal area which relates to cognitive disturbance in schizophrenia Hirsch, S.R.
 2003
 60 1S p. 63-
1 p.
 artikel
614 Mismatch negativity in schizophrenia: Combining FMRI and whole-head meg Kircher, T.T.
 2003
 60 1S p. 252-253
2 p.
 artikel
615 Modeling the potential cost impacts of interventions for early onset schizophrenia Carr, V.J.
 2003
 60 1S p. 333-
1 p.
 artikel
616 Models of substance use in adolescents experiencing a first episode of psychosis Pencer, A.H.
 2003
 60 1S p. 24-
1 p.
 artikel
617 Modified cerebral organization for language in schizophrenia: A functional magnetic resonance imaging study Razafimandimby, A.
 2003
 60 1S p. 232-
1 p.
 artikel
618 Modulating sensory gating in healthy volunteers: The effects of desipramine and haloperidol Oranje, B.
 2003
 60 1S p. 257-
1 p.
 artikel
619 Modulation of alpha 7 nicotinic receptors as a strategy for therapy in schizophrenia Grantham, C.J.
 2003
 60 1S p. 107-
1 p.
 artikel
620 Modulation of brain nerve growth factor and choline-acetyltransferase expression by chronic exposure to haloperidol, risperidone, or olanzapine in rats Parikh, V.
 2003
 60 1S p. 113-114
2 p.
 artikel
621 Modulation of connectivity in the executive and sensorimotor systems prior to spontaneous willed action Spence, S.
 2003
 60 1S p. 233-234
2 p.
 artikel
622 Molecular abnormalities of the hippocampus in severe mental illness: Post-mortem findings from the stanley neuropathology consortium Knable, M.B.
 2003
 60 1S p. 64-
1 p.
 artikel
623 Molecular analysis of N-methyl-D-aspartate receptor NR1 subunit knockdown mice: A model of schizophrenia Wingrove, P.B.
 2003
 60 1S p. 119-
1 p.
 artikel
624 Molecular mechanisms for the putative antipsychotic activity of PDE10A inhibitors: PDE10A regulation of intracellular signaling in striatal medium spiny neurons in culture Menniti, F.S.
 2003
 60 1S p. 313-314
2 p.
 artikel
625 More than one dimension of insight in a first episode follow-up study of non-affective psychosis Drake, R.J.
 2003
 60 1S p. 168-
1 p.
 artikel
626 Morphological and physiological effects of dopamine D2 receptor knockout on the development of inhibitory circuits in the prefrontal cortex of the mouse Roerig, B.
 2003
 60 1S p. 258-259
2 p.
 artikel
627 Mortality experience in three comparative cohorts of patients who received sertindole, risperidone and olanzapine: A hospital-based, retrospective study Branford, D.
 2003
 60 1S p. 353-
1 p.
 artikel
628 Mortality in schizophrenia patients treated with second-generation antipsychotics Kelly, D.L.
 2003
 60 1S p. 41-
1 p.
 artikel
629 Motivational salience — The variable linking dopamine, psychosis, antipsychotics Kapur, S.
 2003
 60 1S p. 100-
1 p.
 artikel
630 Motivation, symptomatology, and functional outcome in schizophrenia: What are the links? Kee, K.S.
 2003
 60 1S p. 172-
1 p.
 artikel
631 Motor cortex FMRI activation changes in schizophrenia Rogowska, J.
 2003
 60 1S p. 232-233
2 p.
 artikel
632 Motor soft neurological signs in first episode schizophrenia: A two-year longitudinal study Chen, E.Y.
 2003
 60 1S p. 129-
1 p.
 artikel
633 MRI study of basal ganglia volume in deficit schizophrenia and apathy induced by traumatic brain injury Strasser, H.C.
 2003
 60 1S p. 207-208
2 p.
 artikel
634 MRI volumetric brain measurements near onset of illness and outcome in schizophrenia: A prospective longitudinal study with five-year follow-up Milev, P.
 2003
 60 1S p. 202-
1 p.
 artikel
635 Multimodal evaluation of executive dysfunctions in schizophrenia Kim, J.
 2003
 60 1S p. 173-
1 p.
 artikel
636 Music perception in schizophrenia: Altered preference for atonal versus tonal sounds Honea, R.
 2003
 60 1S p. 139-
1 p.
 artikel
637 N-acetyl-aspartate levels in the dorsolateral prefrontal region in the first years of schizophrenia are related to illness duration Molina, V.
 2003
 60 1S p. 243-
1 p.
 artikel
638 Negative but not positive symptoms are associated with impairment on an ecologically valid test of executive function Rice, C.D.
 2003
 60 1S p. 154-
1 p.
 artikel
639 Negative priming in first episode psychosis Hopkins, R.S.
 2003
 60 1S p. 139-140
2 p.
 artikel
640 Neonatal lesions of the ventral hippocampus potentiate increases in plasma adrenocorticotropin in response to stress Mitchell, C.P.
 2003
 60 1S p. 148-
1 p.
 artikel
641 Neonatal neurosteroid administration alters adult parvalbumin immunoreactivity in rat prefrontal cortex and thalamus Grobin, A.
 2003
 60 1S p. 57-
1 p.
 artikel
642 Nerve growth factor in never-medicated first episode psychotic and medicated-schizophrenic patients: Possible implications for treatment outcome Evans, D.R.
 2003
 60 1S p. 99-
1 p.
 artikel
643 Neural correlates of impaired motor inhibition in men with a history of violence and mental illness: An FMRI investigation Barkataki, I.
 2003
 60 1S p. 212-
1 p.
 artikel
644 Neural correlates of recognition memory in schizophrenia Weiss, A.P.
 2003
 60 1S p. 236-237
2 p.
 artikel
645 Neural mechanism of predictive smooth pursuit abnormalities in schizophrenia Hong, L.E.
 2003
 60 1S p. 222-
1 p.
 artikel
646 Neurochemistry in chronic schizophrenia: A 4T-proton magnetic resonance spectroscopy study Rowland, L.M.
 2003
 60 1S p. 245-
1 p.
 artikel
647 Neurocognition is associated with day-to-day symptom patterns in schizophrenia patients Kupper, Z.
 2003
 60 1S p. 142-
1 p.
 artikel
648 Neurocognition, symptomatology, and social-adaptive functioning in alcohol-abusing schizophrenia patients Bowie, C.R.
 2003
 60 1S p. 126-
1 p.
 artikel
649 Neurocognitive, behavioural, and neurodevelopmental correlates of schizotypy clusters in adolescents from the general population Barrantes-Vidal, N.
 2003
 60 1S p. 123-
1 p.
 artikel
650 Neurocognitive changes in schizophrenia: Correlates and functional consequences Holthausen, E.A.
 2003
 60 1S p. 139-
1 p.
 artikel
651 Neurocognitive dysfunction in first-episode psychosis: Correlates with symptoms, premorbid adjustment, and duration of untreated psychosis (DUP) Rund, B.R.
 2003
 60 1S p. 155-
1 p.
 artikel
652 Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis Keefe, R.
 2003
 60 1S p. 289-
1 p.
 artikel
653 Neurocognitive enhancement therapy in schizophrenia: Durability of effects on neuropsychological test performance six months after training Bell, M.D.
 2003
 60 1S p. 273-
1 p.
 artikel
654 Neurocognitive functioning and motivation to change drug use behavior in patients with schizophrenia Thomas-Lohrman, S.
 2003
 60 1S p. 27-28
2 p.
 artikel
655 Neurocognitive functioning over the first year of illness in adolescent patients with psychotic disorders Wozniak, J.R.
 2003
 60 1S p. 162-
1 p.
 artikel
656 Neurocognitive markers in prodromal schizophrenia Eastvold, A.D.
 2003
 60 1S p. 133-
1 p.
 artikel
657 Neurocognitive profiles of young people at high-risk versus first episode psychosis: A follow-up study Schall, U.
 2003
 60 1S p. 156-
1 p.
 artikel
658 Neurological signs as a trait marker for schizophrenia Picchioni, M.M.
 2003
 60 1S p. 88-89
2 p.
 artikel
659 Neurological soft signs in psychosis and their evolution over the first four years of illness Whitty, P.
 2003
 60 1S p. 55-
1 p.
 artikel
660 Neurological soft signs in schizophrenia, schizoaffective and bipolar disorder: Diagnosis, asymmetry and gender Quinn, J.
 2003
 60 1S p. 25-
1 p.
 artikel
661 Neurological soft signs (NSSS) in first episode psychosis predict ten year outcome Stirling, J.
 2003
 60 1S p. 158-159
2 p.
 artikel
662 Neurologic cerebellar signs in neuroleptic-naive schizophrenia patients Mola, C.C.
 2003
 60 1S p. 149-
1 p.
 artikel
663 Neuronal gene expression is decreased in prefrontal cortex in schizophrenia Vawter, M.P.
 2003
 60 1S p. 67-
1 p.
 artikel
664 Neuropsychological evaluation on three subtypes of schizophrenia Hwu, H.
 2003
 60 1S p. 5-
1 p.
 artikel
665 Neuropsychological functioning and quality of life in people with schizophrenia enrolled in the schizophrenia care and assessment program Williams, C.
 2003
 60 1S p. 186-
1 p.
 artikel
666 Neuropsychological functioning in first-break, never-medicated adolescents with psychosis Brickman, A.M.
 2003
 60 1S p. 126-127
2 p.
 artikel
667 Neuropsychological functioning in young people at high-risk for psychosis Francey, S.
 2003
 60 1S p. 134-135
2 p.
 artikel
668 Neuropsychological impairments in deficit schizophrenia and apathy after traumatic brain injury Cascella, N.G.
 2003
 60 1S p. 128-
1 p.
 artikel
669 Neuropsychological screening in schizophrenia: Psychometric properties of the repeatable battery for the assessment of neuropsychological status (RBANS) Humber, K.
 2003
 60 1S p. 171-
1 p.
 artikel
670 Neuropsychological status of the first-episode prodrome Hawkins, K.A.
 2003
 60 1S p. 4-
1 p.
 artikel
671 Neurosteroid modulation of GABAergic neurotransmission in the central amygdala Wang, C.J.
 2003
 60 1S p. 263-
1 p.
 artikel
672 Nicotinic receptor A7 auto-antibodies are elevated in the serum of people with schizophrenia Miller, B.E.
 2003
 60 1S p. 101-
1 p.
 artikel
673 No association between the COMT VAL158MET polymorphism and antipsychotic response in schizophrenia Mueller, D.J.
 2003
 60 1S p. 86-
1 p.
 artikel
674 No evidence for altered caudate nucleus volume in neuroleptic-naive first episode patients Tauscher-Wisniewski, S.
 2003
 60 1S p. 209-
1 p.
 artikel
675 No evidence for altered cell density in cortical layers 3 and 5 of Heschl's gyrus in schizophrenia Cotter, D.R.
 2003
 60 1S p. 69-
1 p.
 artikel
676 Nonverbal working memory impairments in schizophrenia patients Gooding, D.C.
 2003
 60 1S p. 170-
1 p.
 artikel
677 Normal cerebral volume asymmetries in early onset schizophrenia Hadjulis, M.
 2003
 60 1S p. 197-
1 p.
 artikel
678 Normalization of working memory in schizophrenia following cognitive remediation: Durability of effects Fiszdon, J.
 2003
 60 1S p. 322-
1 p.
 artikel
679 Nucleus accumbens and thought disorder in childhood-onset schizophrenia: A structural MRI study Ballmaier, M.A.
 2003
 60 1S p. 189-
1 p.
 artikel
680 Obsessive-compulsive symptoms among people with schizophrenia: Relation to psychotic symptoms, cognitive performance and antipsychotic medications Ongur, D.
 2003
 60 1S p. 23-
1 p.
 artikel
681 Obstacles in assessing adherence to oral antipsychotic medications Velligan, D.I.
 2003
 60 1S p. 330-331
2 p.
 artikel
682 Obstetric complications correlate with neurobehavioral and brain structural alterations in young relatives at risk for schizophrenia Gilbert, A.R.
 2003
 60 1S p. 195-
1 p.
 artikel
683 Occupancy of cortical and substantia nigra DA D2 receptors by typical and atypical antipsychotic drugs Kessler, R.M.
 2003
 60 1S p. 242-243
2 p.
 artikel
684 Oculomotor, cognitive and symptom correlates in first-episode schizophrenia using magnetization transfer imaging and volumetric MRI Bagary, M.
 2003
 60 1S p. 189-
1 p.
 artikel
685 Odd speech and the superior temporal gyrus in females with schizotypal personality disorder: A MRI study Dickey, C.
 2003
 60 1S p. 193-
1 p.
 artikel
686 Olanzapine and risperidone in schizophrenia: A randomized double-blind crossover study Irwin, J.
 2003
 60 1S p. 286-
1 p.
 artikel
687 Olanzapine causes greater increases in serum lipids than risperidone Tang, T.
 2003
 60 1S p. 367-
1 p.
 artikel
688 Olanzapine improves apparent motivational deficits more than haloperidol in patients with schizophrenia regardless of concomitant anticholinergic medication use Zhang, F.
 2003
 60 1S p. 308-
1 p.
 artikel
689 Olanzapine improves tardive dyskinesia in patients with schizophrenia Kollack-Walker, S.
 2003
 60 1S p. 359-
1 p.
 artikel
690 Olanzapine induced reductions in frontal lobe lactate levels correlate with treatment response in first episode psychosis Renshaw, P.F.
 2003
 60 1S p. 301-
1 p.
 artikel
691 Olanzapine in non-refractory schizophrenia: Effects on neuropsychology and psychopathology Rozenthal, M.
 2003
 60 1S p. 302-
1 p.
 artikel
692 Olanzapine reduces neuroleptic-induced hyperprolactinemia in schizophrenia Ahl, J.
 2003
 60 1S p. 350-
1 p.
 artikel
693 Olanzapine treatment of residual positive and negative symptoms Buchanan, R.W.
 2003
 60 1S p. 275-
1 p.
 artikel
694 Olanzapine versus placebo for prodromal symptoms Woods, S.W.
 2003
 60 1S p. 306-307
2 p.
 artikel
695 Olanzapine versus placebo treatment of the schizophrenia prodrome: One year results McGlashan, T.H.
 2003
 60 1S p. 295-
1 p.
 artikel
696 Olfaction: Towards a novel mouse endophenotypic model of schizophrenia Kanes, S.J.
 2003
 60 1S p. 109-
1 p.
 artikel
697 Olfactory identification and WAIS-R performance in deficit and nondeficit schizophrenia Seckinger, R.A.
 2003
 60 1S p. 156-157
2 p.
 artikel
698 Olfactory stimulus processing in patients with schizophrenia and their first-degree relatives: Evidence for a genetically-mediated neurophysiological abnormality Turetsky, B.I.
 2003
 60 1S p. 262-
1 p.
 artikel
699 One hertz repetitive transcranial magnetic stimulation delivered to brain areas underlying speech perception reduces persistent auditory hallucinations Hoffman, R.E.
 2003
 60 1S p. 285-286
2 p.
 artikel
700 One-year hospitalization rates in patients with schizophrenia during long-term treatment with long-acting intramuscular risperidone Chue, P.
 2003
 60 1S p. 277-278
2 p.
 artikel
701 Optimal titration for quetiapine: A pilot study Smith, M.A.
 2003
 60 1S p. 303-304
2 p.
 artikel
702 Optimizing the duration of prophylactic use of anti-psychotics after a first psychotic episode in patients with schizophrenia; A decision analytic approach de Vries, S.O.
 2003
 60 1S p. 334-
1 p.
 artikel
703 OPUS project: A randomised controlled trial of integrated psychiatric treatment in first episode psychosis Nordentoft, M.
 2003
 60 1S p. 297-
1 p.
 artikel
704 Oral risperidone + lorazepam versus IM haloperidol + lorazepam in the emergency treatment of acute psychosis in schizophrenia and schizoaffective disorder Gharabawi, G.
 2003
 60 1S p. 284-
1 p.
 artikel
705 Orbitofrontal cortex functioning in schizotypy: Relationship between SPQ ratings and punishment learning van Rijn, S.
 2003
 60 1S p. 161-
1 p.
 artikel
706 Osteoporosis in patients suffering from schizophrenia Hummer, M.
 2003
 60 1S p. 357-
1 p.
 artikel
707 Outcomes benchmarks: Changes in symptom and function outcome measures from year one to year two endpoints with continuous treatment for a schizophrenia spectrum disorder Whitehorn, D.
 2003
 60 1S p. 348-
1 p.
 artikel
708 Parental age and risk for schizophrenia: A nested case-control study Byrne, M.
 2003
 60 1S p. 35-
1 p.
 artikel
709 Parental separation at birth and mental health in adulthood Veijola, J.
 2003
 60 1S p. 53-
1 p.
 artikel
710 Pathways into care in early psychosis Ehmann, T.
 2003
 60 1S p. 38-
1 p.
 artikel
711 Pathways to care in early psychosis Cougnard, A.
 2003
 60 1S p. 37-
1 p.
 artikel
712 Patient-family contact may improve outcomes of behaviorally-based rehabilitation programs Glynn, S.M.
 2003
 60 1S p. 323-
1 p.
 artikel
713 Patterns of use of olanzapine in the inpatient treatment of acute schizophrenia: A multivariate approach of the EUROPA study Ciudad, A.
 2003
 60 1S p. 278-
1 p.
 artikel
714 Patterns of visual processing in schizophrenia: Selective dorsal pathway impairment King, J.P.
 2003
 60 1S p. 173-
1 p.
 artikel
715 PDE10A knockout mice: Behavioral characterization and effects of papaverine, a PDE10A inhibitor Siuciak, J.
 2003
 60 1S p. 116-
1 p.
 artikel
716 Perception of dynamic expressions of fear by patients with schizophrenia: A symptom-based investigation Russell, T.A.
 2003
 60 1S p. 181-
1 p.
 artikel
717 Perceptions of sexual functioning, prolactin levels and psychopathology in an olanzapine switch trial Dickson, R.A.
 2003
 60 1S p. 281-
1 p.
 artikel
718 Perceptual and working memory impairments in first-episode and chronic schizophrenia Mathes, B.
 2003
 60 1S p. 145-146
2 p.
 artikel
719 Perinatal predictors of neuropsychological outcome in young adults born preterm Cuddy, M.C.
 2003
 60 1S p. 131-
1 p.
 artikel
720 Perospirone-induced mania in schizophrenia Yokoshima, T.
 2003
 60 1S p. 371-
1 p.
 artikel
721 Peroxisome-proliferator activated receptors (PPAR): Possible involvement in schizophrenia Horrobin, D.F.
 2003
 60 1S p. 99-
1 p.
 artikel
722 Personality and symptom dimensions in acute schizophrenia Guillem, F.
 2003
 60 1S p. 16-17
2 p.
 artikel
723 PET imaging of dopamine D1 and D2 receptors in patients treated with clozapine, olanzapine, quetiapine, or risperidone Tauscher, J.
 2003
 60 1S p. 246-
1 p.
 artikel
724 Pharmacological activity of aripiprazole at presynaptic and postsynaptic dopamine receptors Bymaster, F.
 2003
 60 1S p. 310-
1 p.
 artikel
725 Physical illness and lifestyle risk factors in first presentation patients with psychosis Samele, C.
 2003
 60 1S p. 49-
1 p.
 artikel
726 Plasma homovanillic acid differences between predominant positive and negative first-episode schizophrenic patients Bernardo, M.
 2003
 60 1S p. 98-
1 p.
 artikel
727 Plasma leptin in treated patients with schizophrenia Haupt, D.W.
 2003
 60 1S p. 356-
1 p.
 artikel
728 Plasma levels of interleukin-12 in drug-naive schizophrenic patients: Changes associated with clinical response to neuroleptic treatment Crespo-Facorro, B.
 2003
 60 1S p. 98-
1 p.
 artikel
729 31P MRS evidence of an association between cognitive impairment and membrane phospholipid alterations in chronic schizophrenia Pettegrew, J.W.
 2003
 60 1S p. 244-245
2 p.
 artikel
730 Polymorphisms in the dopamine D3 receptor gene and improvement in positive symptoms of schizophrenia Staddon, S.
 2003
 60 1S p. 90-91
2 p.
 artikel
731 Polymorphisms in the EMX2 homeo☐ gene in schizophrenia and bipolar disorder Sabunciyan, S.H.
 2003
 60 1S p. 89-90
2 p.
 artikel
732 Poor insight in the psychoses: Neurocognitive impairment or psychological defence? An analysis of competing models Morgan, K.
 2003
 60 1S p. 202-
1 p.
 artikel
733 Positive and negative affect in schizophrenia across social daily life situations Vansteelandt, K.
 2003
 60 1S p. 28-
1 p.
 artikel
734 Postcode prescribing for schizophrenia Hayhurst, K.P.
 2003
 60 1S p. 337-
1 p.
 artikel
735 Post-onset cognitive decline in schizophrenia is relatively selective for executive-abstraction function Kremen, W.S.
 2003
 60 1S p. 141-142
2 p.
 artikel
736 Postural stability in schizophrenia Marvel, C.L.
 2003
 60 1S p. 145-
1 p.
 artikel
737 Pramipexole augments benefits of atypical antipsychotics in patients with schizophrenia or schizoaffective disorder Kelleher, J.P.
 2003
 60 1S p. 289-
1 p.
 artikel
738 Predicting patterns of change in delusional conviction, pre-occupation, fear and well-being during cognitive behavioral therapy van der Gaag, M.
 2003
 60 1S p. 330-
1 p.
 artikel
739 Predictors and five-year outcome in early-onset schizophrenia. A path analysis Lenior, M.E.
 2003
 60 1S p. 292-
1 p.
 artikel
740 Predictors of antipsychotic treatment response in patients with first episode schizophrenia, schizoaffective, and schizophreniform disorders Perkins, D.O.
 2003
 60 1S p. 24-
1 p.
 artikel
741 Predictors of number and severity of violence episodes in a one-year follow-up schizophrenia sample Bobes, J.
 2003
 60 1S p. 333-
1 p.
 artikel
742 Predictors of two-year follow-up in children and adolescents with schizophrenia Sporn, A.L.
 2003
 60 1S p. 304-
1 p.
 artikel
743 Prefrontal cortical dopamine denervation decreases dendritic spine density in pyramidal neurons Deutsch, A.Y.
 2003
 60 1S p. 56-
1 p.
 artikel
744 Prefrontal cortical dysfunction and genetic polymorphisms of the COMT gene in subjects with schizophrenia: A genetic study of a schizophrenia endophenotype Wonodi, I.
 2003
 60 1S p. 91-92
2 p.
 artikel
745 Pregnancy, lactation and treatment with antipsychotic drugs Mertens, C.
 2003
 60 1S p. 325-326
2 p.
 artikel
746 Pregnancy outcome in women receiving atypical antipsychotic drugs: A prospective, multicentre, controlled study Levinson, A.J.
 2003
 60 1S p. 361-
1 p.
 artikel
747 Preliminary cost analysis of treating schizophrenia with amisulpride: An ongoing naturalistic mirror image study Surguladze, S.
 2003
 60 1S p. 345-346
2 p.
 artikel
748 Preliminary FMRI evidence for a hyperactive magnocellular visual pathway in first-degree relatives of persons with schizophrenia Bedwell, J.S.
 2003
 60 1S p. 213-
1 p.
 artikel
749 Premorbid abnormalities in psychotic patients are associated with schizotypy in their relatives Mata, I.
 2003
 60 1S p. 85-86
2 p.
 artikel
750 Premorbid function and early development in early onset schizophrenia Vourdas, A.
 2003
 60 1S p. 29-
1 p.
 artikel
751 Premorbid functioning as a predictor of clozapine response in treatment refractory schizophrenia Feldman, S.M.
 2003
 60 1S p. 282-
1 p.
 artikel
752 Prenatal injections with the antimitotic agent AraC causes gating deficits in adult rats Vogel, M.W.
 2003
 60 1S p. 59-
1 p.
 artikel
753 Prenatal methylazoxymethanol treatment in the rat: A neurodevelopmental model for studying cognitive deficits in schizophrenia? Gourevitch, R.
 2003
 60 1S p. 57-
1 p.
 artikel
754 Prenatal stress produces behavioural and molecular phenotypic changes that mimic aspects of schizophrenia Kinnunen, A.K.
 2003
 60 1S p. 109-110
2 p.
 artikel
755 Prepulse facilitation deficits in a passive task in schizophrenia patients and their siblings Wynn, J.K.
 2003
 60 1S p. 264-
1 p.
 artikel
756 Prepulse inhibition of the startle response and extrastriatal D2/D3-dopamine receptor binding in drug-naive first-episode schizophrenic patients and healthy controls Glenthoj, B.Y.
 2003
 60 1S p. 241-
1 p.
 artikel
757 Presenting symptoms as a predictor of the nature of psychotic illness in admissions to a psychiatric unit Hutchinson, G.
 2003
 60 1S p. 18-
1 p.
 artikel
758 Prevalence and measurement of memory impairment in schizophrenia Al-Uzri, M.M.
 2003
 60 1S p. 32-
1 p.
 artikel
759 Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with medication variables Yusufi, B.Z.
 2003
 60 1S p. 371-
1 p.
 artikel
760 Prevalence of adult-onset diabetes among outpatients receiving antipsychotic drugs Lamberti, J.
 2003
 60 1S p. 360-
1 p.
 artikel
761 Primary visual cortex in schizophrenia — A stereological study of area 17 volume and total neuron number Dorph-Petersen, K.
 2003
 60 1S p. 70-
1 p.
 artikel
762 Primary visual dysfunction in schizophrenia: Relationship to white matter integrity inferred from diffusion tensor imaging Butler, P.D.
 2003
 60 1S p. 190-191
2 p.
 artikel
763 Principal components analysis of hippocampal shape in schizophrenia Saykin, A.J.
 2003
 60 1S p. 206-
1 p.
 artikel
764 Prism adaptation in schizophrenia Bigelow, N.O.
 2003
 60 1S p. 124-
1 p.
 artikel
765 Probabilistic reasoning bias in schizophrenia — The role of memory Menon, M.
 2003
 60 1S p. 176-
1 p.
 artikel
766 Processing of word-level and paragraph-level information in schizotypy Niznikiewicz, M.A.
 2003
 60 1S p. 256-257
2 p.
 artikel
767 Profile analysis of the Wechsler adult intelligence scale — III in schizophrenia, bipolar disorder, and depression Christensen, B.K.
 2003
 60 1S p. 130-
1 p.
 artikel
768 Profile of cognitive functioning in patients with schizophrenia in specialized classes Chouinard, S.
 2003
 60 1S p. 129-130
2 p.
 artikel
769 Profiles of cognitive impairment in schizophrenia and Parkinson's disease Nassika, Z.
 2003
 60 1S p. 150-
1 p.
 artikel
770 Progesterone elevations related to symptom severity in first break schizophrenia Prior, T.I.
 2003
 60 1S p. 101-102
2 p.
 artikel
771 Progressive cortical gray matter loss in adolescence is specific to schizophrenia Gogtay, N.
 2003
 60 1S p. 196-
1 p.
 artikel
772 Progressive focal gray matter density changes in speech related areas in schizophrenia Cahn, W.
 2003
 60 1S p. 191-
1 p.
 artikel
773 Progressive frontal lobe reduction in first episode psychosis Sun, D.
 2003
 60 1S p. 208-
1 p.
 artikel
774 Project ice storm: A prospective study of the effects of prenatal maternal stress on other risk factors for schizophrenia King, S.
 2003
 60 1S p. 41-42
2 p.
 artikel
775 Prolactin levels in children after long term treatment with risperidone Findling, R.
 2003
 60 1S p. 354-355
2 p.
 artikel
776 Prospective evaluation of insulin sensitivity by the hyperinsulinemic, euglycemic clamp in healthy volunteers treated with olanzapine, risperidone or placebo Beasley, C.M.
 2003
 60 1S p. 309-
1 p.
 artikel
777 Prospective longitudinal FMRI study of prefrontal cortex based context processing in never medicated first-episode schizophrenia Carter, C.S.
 2003
 60 1S p. 214-
1 p.
 artikel
778 Prospective memory in schizophrenia Ritch, J.L.
 2003
 60 1S p. 180-
1 p.
 artikel
779 Prospective study of adult neuropsychological function in offspring of women with different psychoses Schubert, E.
 2003
 60 1S p. 156-
1 p.
 artikel
780 Proton magnetic resonance spectroscopy (1H-MRS) in adolescents at risk for schizophrenia: The Edmonton high risk project Tibbo, P.
 2003
 60 1S p. 246-
1 p.
 artikel
781 Proton magnetic resonance spectroscopy of the thalamus and temporal lobes in schizophrenia Delamillieure, P.
 2003
 60 1S p. 240-
1 p.
 artikel
782 Proton MR spectroscopy in first episode psychosis Wood, S.
 2003
 60 1S p. 247-
1 p.
 artikel
783 Psychoacoustic evidence of impaired frequency, duration and intensity discrimination in schizophrenia Rojas, D.C.
 2003
 60 1S p. 181-
1 p.
 artikel
784 Psychological stress impairs P50 suppression in schizotypy White, P.M.
 2003
 60 1S p. 263-
1 p.
 artikel
785 Psychometric relationships of insight in patients with schizophrenia who commits violent acts Friedman, L.
 2003
 60 1S p. 81-
1 p.
 artikel
786 Psychopathological influences on self-rated and external assessments of quality of life in schizophrenia Massie, J.
 2003
 60 1S p. 22-
1 p.
 artikel
787 Psychopathology, attentional functioning and plasma-homovanillic acid levels in earlier and later onset schizophrenia Baeza, I.
 2003
 60 1S p. 3-
1 p.
 artikel
788 Psychosis is associated with changes in myelinated white matter Garver, D.L.
 2003
 60 1S p. 194-
1 p.
 artikel
789 Psychosocial and psychpathological assessment in chronic patients and their family members: An insight into quality of life (QOL) Palha, A.P.
 2003
 60 1S p. 7-
1 p.
 artikel
790 Quality of life in schizophrenia: The relationship between participant self-report and clinical assessment Russo, P.A.
 2003
 60 1S p. 343-344
2 p.
 artikel
791 Quality of life: Instrument validation in serious mental illness Walling, D.P.
 2003
 60 1S p. 347-
1 p.
 artikel
792 Quantitative and qualitative phenotypes for thought disorder: Implications for linkage studies of schizophrenia Levy, D.L.
 2003
 60 1S p. 84-
1 p.
 artikel
793 Quetiapine attenuates the immobilization-induced decrease of brain-derived neurotrophic factor in rat hippocampus Li, X.
 2003
 60 1S p. 111-
1 p.
 artikel
794 Random-assignment, double-blind, clinical trial of once- versus twice-daily administration of quetiapine in patients with schizophrenia or schizoaffective disorder Parepally, H.
 2003
 60 1S p. 298-
1 p.
 artikel
795 Randomized assessment of strategies for switching patients with sub-optimal treatment outcomes from olanzapine to risperidone Ganguli, R.
 2003
 60 1S p. 283-
1 p.
 artikel
796 Rapid detection of the deletion genotype for the partially duplicated alpha 7 gene using the transgenomic wave DHPLC polymorphism detection system Lee, M.J.
 2003
 60 1S p. 94-
1 p.
 artikel
797 Rapid improvement of subjective well-being after successful switch of psychotic outpatients to olanzapine: Results from an open-label phase III study Kluge, M.
 2003
 60 1S p. 290-
1 p.
 artikel
798 Rate of recidivism in a public psychiatric hospital Shurett, R.B.
 2003
 60 1S p. 8-9
2 p.
 artikel
799 Reasoning styles and delusions in early psychosis Broome, M.
 2003
 60 1S p. 12-13
2 p.
 artikel
800 Recall bias in patients with schizophrenia Brill, N.
 2003
 60 1S p. 166-167
2 p.
 artikel
801 Recognition of facial affects: An examination of event related potentials in schizophrenic patients Heinz, G.F.
 2003
 60 1S p. 251-
1 p.
 artikel
802 Recognition of universal emotions in stable schizophrenia patients Kohler, C.G.
 2003
 60 1S p. 173-
1 p.
 artikel
803 Recovery in first episode schizophrenia Robinson, D.G.
 2003
 60 1S p. 301-
1 p.
 artikel
804 Recovery therapy: A dissemination and effectiveness trial of a broad CBT for psychosis Farhall, J.
 2003
 60 1S p. 321-322
2 p.
 artikel
805 Red cell omega 3 and omega 6 fatty acids in relation to schizotypal traits in healthy adults Richardson, A.J.
 2003
 60 1S p. 102-
1 p.
 artikel
806 Reduced levels of specific autobiographical memories in schizophrenia Danion, J.
 2003
 60 1S p. 167-
1 p.
 artikel
807 Reduced mossy fiber sprouting in temporal lobe epilepsy with psychosis: The role of brain derived neurotrophic factor and TRKB Dunham, J.S.
 2003
 60 1S p. 70-
1 p.
 artikel
808 Reduced rural incidence of schizophrenia is primarily a female phenomenon: The Cavan-Monaghan first episode study at seven years Baldwin, P.A.
 2003
 60 1S p. 33-
1 p.
 artikel
809 Reduced white matter integrity in recent-onset schizophrenia as assessed with diffusion tensor imaging Peters, B.D.
 2003
 60 1S p. 204-205
2 p.
 artikel
810 Reducing rehospitalization rates for patients with schizophrenia: The community re-entry supplemental intervention Rossotto, E.
 2003
 60 1S p. 328-
1 p.
 artikel
811 Reduction in negative symptoms of schizophrenia during long-term therapy with aripiprazole Archibald, D.G.
 2003
 60 1S p. 271-
1 p.
 artikel
812 Reduction of GAD-67 MRNA in the striatum of patients with schizophrenia and bipolar disorder Shannon-Weickert, C.
 2003
 60 1S p. 66-
1 p.
 artikel
813 Reelin as a candidate gene for schizophrenia Dempster, E.L.
 2003
 60 1S p. 93-94
2 p.
 artikel
814 Reelin MRNA is decreased in neurons of the hippocampus and temporal cortex in schizophrenia: A cellular in situ hybridisation study Eastwood, S.L.
 2003
 60 1S p. 71-
1 p.
 artikel
815 Reelin-related gene and schizophrenia Nanko, S.
 2003
 60 1S p. 88-
1 p.
 artikel
816 Regional cerebellar anatomy and formal thought disorder in childhood-onset schizophrenia Blanton, R.E.
 2003
 60 1S p. 189-190
2 p.
 artikel
817 Regional cerebral blood flow abnormalities in posterior cingulate of psychotic temporal lobe epileptic patients Hallak, J.E.
 2003
 60 1S p. 219-220
2 p.
 artikel
818 Regional extra-cortical CSF increases despite absence of significant gray matter losses in schizophrenia Narr, K.L.
 2003
 60 1S p. 202-203
2 p.
 artikel
819 Regional grey matter reduction in people with schizophrenia demonstrated by voxel-based morphometry Wignall, E.L.
 2003
 60 1S p. 211-
1 p.
 artikel
820 Regional hippocampal abnormalities in schizophrenia: RCBF and neurochemical changes are confined to the anterior portion Tamminga, C.
 2003
 60 1S p. 67-
1 p.
 artikel
821 Regionally localized thinning of the cerebral cortex in schizophrenia Kuperberg, G.R.
 2003
 60 1S p. 199-200
2 p.
 artikel
822 Relation between auditory attentional deficits and neuroanatomical systems in schizophrenia Lopez, P.
 2003
 60 1S p. 227-228
2 p.
 artikel
823 Relation of cognition and schizophrenia diagnosis in predicting shopping performance Rempfer, M.
 2003
 60 1S p. 180-
1 p.
 artikel
824 Relation of motion processing and contrast detection and its implication in schizophrenia Chen, Y.
 2003
 60 1S p. 265-
1 p.
 artikel
825 Relationship between plasma leptin and memory performance in humans with and without schizophrenia Melson, A.K.
 2003
 60 1S p. 147-148
2 p.
 artikel
826 Relationship between positive and negative symptoms of schizophrenia and dimensions of personality pathology in biological parents Subotnik, K.L.
 2003
 60 1S p. 91-
1 p.
 artikel
827 Relationship between symptom dimensions and frontal lobe functions in schizophrenia John, J.P.
 2003
 60 1S p. 140-
1 p.
 artikel
828 Relationships among cognitive and electrophysiological schizophrenia phenotypes Thaker, G.K.
 2003
 60 1S p. 269-
1 p.
 artikel
829 Relationships matter: The impact of the therapeutic alliance on outcome in schizophrenia Bentall, R.P.
 2003
 60 1S p. 319-
1 p.
 artikel
830 Relatives' negative affect and the course of schizophrenia in African-American patients Rosenfarb, I.S.
 2003
 60 1S p. 328-
1 p.
 artikel
831 Relaxation effects in quantitative MRS in schizophrenia Olson, D.P.
 2003
 60 1S p. 244-
1 p.
 artikel
832 Relevance of olfactory processing to schizophrenia: Testing a brief assessment tool for odor identification research Goudsmit, N.
 2003
 60 1S p. 136-137
2 p.
 artikel
833 Remote associations and working memory in schizophrenia: Implication for verbal creativity Doop, M.L.
 2003
 60 1S p. 132-133
2 p.
 artikel
834 REM sleep EEG activity correlates with cognitive performance in first-episode, neuroleptic-naive patients with schizophrenia Poulin, J.
 2003
 60 1S p. 152-
1 p.
 artikel
835 Reproductive patterns in schizophrenic patients and their relatives in an inner city East London catchment area Bass, N.J.
 2003
 60 1S p. 78-
1 p.
 artikel
836 Responsiveness to antipsychotic treatment in first-episode psychotic patients, relation with duration of untreated psychosis (DUP) Pelayo-Teran, J.
 2003
 60 1S p. 23-24
2 p.
 artikel
837 Restriction fragment differential display using BA 46 from subjects with schizophrenia: A role for cell adhesion and signal transduction in the pathology of the disorder Dean, B.
 2003
 60 1S p. 61-
1 p.
 artikel
838 Results from the schizophrenia outpatient health outcomes (SOHO) study: Quality of life and subjective well-being under neuroleptic treatment from the German sample Naber, D.
 2003
 60 1S p. 341-
1 p.
 artikel
839 Results of multifamily hit-treatment for psychotic patients with persistent auditory hallucinations: A pilot-study Jenner, J.A.
 2003
 60 1S p. 287-
1 p.
 artikel
840 Retrieval induced forgetting: Assessing associative memory in schizophrenia Allen, C.G.
 2003
 60 1S p. 121-
1 p.
 artikel
841 Retrogression of schizophrenia? Vinar, O.
 2003
 60 1S p. 28-29
2 p.
 artikel
842 Retrospective assessment of pre-existing diabetes progression in clinical trials of patients with serious mental illness Wang, H.
 2003
 60 1S p. 369-
1 p.
 artikel
843 Retrospective assessment of risk factors for treatment emergent glucose abnormalities during randomized, double-blind clinical trials of medications for treatment of schizophrenia Sowell, M.O.
 2003
 60 1S p. 366-367
2 p.
 artikel
844 RGS gene expression changes in the dopaminergic system by specific D1 and D2 agents: Clues for receptor selectivity of RGS proteins Taymans, J.
 2003
 60 1S p. 58-
1 p.
 artikel
845 Risk factors for compliance with harmful command hallucinations in psychotic disorders Shawyer, F.
 2003
 60 1S p. 25-26
2 p.
 artikel
846 Risk factors for coronary heart disease in longer-term patients on antipsychotic medication: High prevalence of syndrome X Cohn, T.A.
 2003
 60 1S p. 353-354
2 p.
 artikel
847 Risk factors for death in schizophrenic patients: A nested case control study Francois, C.
 2003
 60 1S p. 355-
1 p.
 artikel
848 Risk factors for suicide in schizophrenia and schizoaffective disorder Barnett, B.E.
 2003
 60 1S p. 3-4
2 p.
 artikel
849 Risperidone but not haloperidol triggers neurogenesis in the subventricular zone and migration to the olfactory bulb in rats: Possible implications for improved olfaction Khan, M.
 2003
 60 1S p. 109-
1 p.
 artikel
850 Risperidone prevents and restores haloperidol-induced oxidative stress-mediated brain injury Mahadik, S.
 2003
 60 1S p. 112-
1 p.
 artikel
851 Risperidone (risperdal®) in the treatment of acute schizophrenia Raedler, T.J.
 2003
 60 1S p. 300-
1 p.
 artikel
852 RNA expression profiling reveals alterations in lipid metabolism-related molecules in response to antipsychotic drug treatment: Insights into the pathophysiology of psychiatric disorders Thomas, E.A.
 2003
 60 1S p. 316-317
2 p.
 artikel
853 RNA profiling on the anterior cingulate in schizophrenia Buxton, F.
 2003
 60 1S p. 93-
1 p.
 artikel
854 Saccadic performance among healthy young adults and the supporting neural correlates as identified using FMRI McDowell, J.E.
 2003
 60 1S p. 228-
1 p.
 artikel
855 Saccadic performance and associated cortical potentials in schizophrenia patients and their first-degree relatives Dionisio, D.P.
 2003
 60 1S p. 265-
1 p.
 artikel
856 Safety and efficacy of olanzapine in treating patients with schizophrenia Bitter, I.
 2003
 60 1S p. 273-274
2 p.
 artikel
857 Safety and tolerability meta-analysis of aripiprazole in schizophrenia Stock, E.
 2003
 60 1S p. 367-
1 p.
 artikel
858 Safety and tolerability of aripiprazole in patients with schizophrenia stratified by race Lam, S.
 2003
 60 1S p. 291-
1 p.
 artikel
859 Safety and tolerability of high-dose quetiapine in treatment refactory schizophrenia: Preliminary results from an open-label trial Nelson, M.W.
 2003
 60 1S p. 363-
1 p.
 artikel
860 Scale for auditory speech hallucinations (SASH), reliability Stephane, M.
 2003
 60 1S p. 26-
1 p.
 artikel
861 Scalp topography of resting EEG frequency abnormalities in schizophrenia patients and relatives of schizophrenia patients McGuire, K.
 2003
 60 1S p. 255-
1 p.
 artikel
862 Schizo-obsessive phenomena in schizophrenic and OCD patients. Results from a cross-sectional and phenomenological study Lo´yzaga, C.
 2003
 60 1S p. 20-21
2 p.
 artikel
863 Schizophrenia and affective disorder show different visual scanpath patterns to faces and facial expressions: Is this a trait versus state-based distinction? Loughland, C.M.
 2003
 60 1S p. 267-
1 p.
 artikel
864 Schizophrenia and psychiatric services use in Turkey among initiators of olanzapine or risperidone Nitz, N.M.
 2003
 60 1S p. 341-
1 p.
 artikel
865 Schizophrenia and use of antipsychotics: Prevalence of overweight, lipid abnormalities and diabetes mellitus Bassitt, D.P.
 2003
 60 1S p. 352-
1 p.
 artikel
866 Schizophrenia, brain volumes and genetics: An MZ twin model van Haren, N.E.
 2003
 60 1S p. 210-211
2 p.
 artikel
867 Schizophrenia care and assessment program (SCAP): Examination of treatment pattern differences by race Mark, T.L.
 2003
 60 1S p. 339-340
2 p.
 artikel
868 Schizophrenia care and assessment program (SCAP): The impact of clinical and functional characteristics and antipsychotic medication treatment on outpatient and inpatient psychiatric utilization Palmer, L.A.
 2003
 60 1S p. 342-
1 p.
 artikel
869 Schizophrenia comprises membrane dysfunction Wiesel, F.
 2003
 60 1S p. 102-103
2 p.
 artikel
870 Schizophrenia in late Victorian and Edwardian England Nixon, N.
 2003
 60 1S p. 47-
1 p.
 artikel
871 Schizophrenia in the offspring of antenatally depressed mothers — A thirty one year follow-up of the Northern Finland 1966 birth cohort Ma¨ki, P.H.
 2003
 60 1S p. 44-
1 p.
 artikel
872 Schizophrenia in the offspring of Israeli mothers of different origins Goetz, D.
 2003
 60 1S p. 39-
1 p.
 artikel
873 Schizophrenia, marital status, and employment: A forty-year study Agerbo, E.
 2003
 60 1S p. 32-
1 p.
 artikel
874 Schizophrenia patients fail to activate neural substrates that are critical for computation of outcome success and reward magnitude during decision-making Paulus, M.P.
 2003
 60 1S p. 231-
1 p.
 artikel
875 Schizophrenia patients inhibit motor responses just-in-the nick-of-time: ERP and FMRI in a go/NoGo task Ford, J.M.
 2003
 60 1S p. 217-218
2 p.
 artikel
876 Schizophrenia patients show a mild but significant impairment of transfer generalization in a learned visual discrimination task Titone, D.
 2003
 60 1S p. 159-
1 p.
 artikel
877 Schizophrenia patients show prolonged attentional blink: Evidence for dysfunctional filtering to conscious awareness Zorrilla, L.T. Eyler
 2003
 60 1S p. 169-
1 p.
 artikel
878 Schizophrenic-like deficits in nonpsychotic children and adolescents with 22Q11 deletion syndrome Kwapil, T.R.
 2003
 60 1S p. 83-84
2 p.
 artikel
879 Schizotypal traits and spatial ability in children Cyhlarova, E.
 2003
 60 1S p. 13-14
2 p.
 artikel
880 Schizotypy and alexithymia in hallucination-prone individuals van 't Wout, M.
 2003
 60 1S p. 160-161
2 p.
 artikel
881 Schizotypy and patterns of lateral asymmetry on hemisphere-specific language tasks Russell, A.
 2003
 60 1S p. 155-
1 p.
 artikel
882 Screening for prodromal symptoms of psychosis in treatment-seeking adolescents Loewy, R.L.
 2003
 60 1S p. 6-
1 p.
 artikel
883 Screening the ‘receptorome’ to discover novel proximal molecular targets of atypical antipsychotic drug actions Roth, B.L.
 2003
 60 1S p. 314-315
2 p.
 artikel
884 Second replication of disturbed pre-alpha-cell migration in the entorhinal cortex of schizophrenic patients Falkai, P.G.
 2003
 60 1S p. 71-
1 p.
 artikel
885 Selective anterior cingulate dysfunction during cognitive interference in schizophrenia Heckers, S.
 2003
 60 1S p. 220-
1 p.
 artikel
886 Self-identification in patients with schizophrenia Clemmons, C.
 2003
 60 1S p. 130-
1 p.
 artikel
887 Semiotic cognitive breakdown in schizophrenia and SPD Buoiano, G.
 2003
 60 1S p. 127-
1 p.
 artikel
888 Sensorimotor gating deficits and psychosis in acutely hospitalized psychiatric patients Perry, W.
 2003
 60 1S p. 258-
1 p.
 artikel
889 Sensory gating in infants Kisley, M.A.
 2003
 60 1S p. 253-
1 p.
 artikel
890 Sensory gating in schizophrenia: Clinical, P50, and PPI measures Patterson, J.
 2003
 60 1S p. 257-258
2 p.
 artikel
891 Sentence processing and temporal lobe function in schizophrenia: A functional magnetic resonance imaging study Rapp, A.M.
 2003
 60 1S p. 231-232
2 p.
 artikel
892 September 11, 2001: A fair degree of indifference in schizophrenia Stip, E.
 2003
 60 1S p. 26-
1 p.
 artikel
893 Sequential IM/oral ziprasidone versus haloperidol in schizophrenia with anxiety Brook, S.
 2003
 60 1S p. 275-
1 p.
 artikel
894 Serial testing for clinical trials: Practice effects and reliability in patients with schizophrenia and healthy volunteers Beglinger, L.J.
 2003
 60 1S p. 123-
1 p.
 artikel
895 Serologic evidence for prenatal influenza in the etiology of schizophrenia Brown, A.S.
 2003
 60 1S p. 34-
1 p.
 artikel
896 Sertindole is associated with reduction in health-care resource use for patients with schizophrenia Ereshefsky, L.
 2003
 60 1S p. 335-336
2 p.
 artikel
897 Sertindole is well tolerated and superior to risperidone with respect to efficacy in patients with schizophrenia Azorin, J.
 2003
 60 1S p. 271-272
2 p.
 artikel
898 Sertindole safety and exposure: A retrospective study on 8608 patients in Europe Peuskens, J.
 2003
 60 1S p. 364-365
2 p.
 artikel
899 Sertindole shows advantageous cognitive profile in the morris water maze Didriksen, M.
 2003
 60 1S p. 168-
1 p.
 artikel
900 Sertindole treatment does not increase mortality in schizophrenics-marketing suspension lifted Sturkenboom, M.C.
 2003
 60 1S p. 367-
1 p.
 artikel
901 Severity of baseline positive symptoms predicts psychosis in adolescents prodromal for schizophrenia Lencz, T.
 2003
 60 1S p. 20-
1 p.
 artikel
902 Sex differences in frontal lobe white matter integrity in healthy humans: A diffusion tensor imaging study Szeszko, P.R.
 2003
 60 1S p. 208-209
2 p.
 artikel
903 Sex differences in psychosis: Normal or pathological? Spauwen, J.
 2003
 60 1S p. 50-
1 p.
 artikel
904 Sex differences in the symptoms of psychosis in general population sample Maric, N.P.
 2003
 60 1S p. 21-22
2 p.
 artikel
905 Sexual and hormonal profile of male patients with schizophrenia undergoing antipsychotic treatment: A Brazilian sample Costa, A.
 2003
 60 1S p. 278-279
2 p.
 artikel
906 Sexual and physical abuse in women with schizophrenia: Prevalence and risk factors Gearon, J.S.
 2003
 60 1S p. 38-39
2 p.
 artikel
907 Sexual dysfunctions and prolactin levels in patients using classical or modern antipsychotics Knegtering, R.
 2003
 60 1S p. 358-359
2 p.
 artikel
908 Shank proteins in the superior temporal cortex of patients with schizophrenia Hashimoto, T.
 2003
 60 1S p. 63-
1 p.
 artikel
909 Short- and long-term recovery of cognitive functioning following the first episode of schizophrenia Haas, G.L.
 2003
 60 1S p. 137-
1 p.
 artikel
910 Sibling bond and coping with heredity in schizophrenia Sta˚lberg, G.
 2003
 60 1S p. 184-
1 p.
 artikel
911 SLV310, a molecule combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition Kruse, C.G.
 2003
 60 1S p. 110-
1 p.
 artikel
912 SM-13496 in patients with acute exacerbation of schizophrenia: A two-dose double-blind phase II comparison with placebo Ogasa, M.
 2003
 60 1S p. 297-
1 p.
 artikel
913 Smoking, caffeine intake and eating habits in community dwelling patients with schizophrenia Brar, J.S.
 2003
 60 1S p. 34-
1 p.
 artikel
914 Smoking differentially modulates hippocampal transcriptional profiles in schizophrenics and controls: A microarray analytical approach Wang, S.
 2003
 60 1S p. 97-
1 p.
 artikel
915 Smoking in schizophrenic patients with and without substance abuse disorder Hammond, R.
 2003
 60 1S p. 17-
1 p.
 artikel
916 Smooth pursuit eye movement abnormalities in children with and vulnerable to schizophrenia Ross, R.G.
 2003
 60 1S p. 268-269
2 p.
 artikel
917 Social anhedonia and schizophrenia-proneness: Initial results from the Maryland longitudinal study of schizotypy Blanchard, J.J.
 2003
 60 1S p. 165-
1 p.
 artikel
918 Social cognition in first episode psychosis Addington, J.
 2003
 60 1S p. 163-
1 p.
 artikel
919 Social cognition in schizophrenic and bipolar subjects treated with olanzapine Mazza, M.
 2003
 60 1S p. 175-
1 p.
 artikel
920 Social outcome in early psychosis: A two year follow-up Voges, M.A.
 2003
 60 1S p. 29-
1 p.
 artikel
921 Social outcome of schizophrenia after treatment with clozapine: An open trial Jagadisha,
 2003
 60 1S p. 286-287
2 p.
 artikel
922 Social recognition in mice: Behavioral disruption with ketamine and blockade with antipsychotic drug White, A.N.
 2003
 60 1S p. 119-
1 p.
 artikel
923 Sound and vision, using popular media to improve knowledge about schizophrenia Thys, E.
 2003
 60 1S p. 52-
1 p.
 artikel
924 Source memory biases associated with reality distortion in schizophrenia Woodward, T.
 2003
 60 1S p. 186-187
2 p.
 artikel
925 Source monitoring and communication disturbance in schizophrenia Nienow, T.M.
 2003
 60 1S p. 151-
1 p.
 artikel
926 Spatial context effects on visuo-spatial working memory (VSWM) in schizophrenia Lee, J.
 2003
 60 1S p. 143-
1 p.
 artikel
927 Spatial working memory deficits in first-episode psychosis: Relationship with negative symptoms McConchie, M.A.
 2003
 60 1S p. 146-
1 p.
 artikel
928 Specifying abnormal processing in working memory deficits of schizophrenia; why and what do they forget? Park, S.
 2003
 60 1S p. 152-
1 p.
 artikel
929 Spontaneous improvement in severe, chronic schizophrenia and its neuropsychological correlates Murray, G.
 2003
 60 1S p. 150-
1 p.
 artikel
930 Stability of expression of schizotypal negative and positive dimensions from adolescence to young adulthood Squires-Wheeler, E.
 2003
 60 1S p. 9-
1 p.
 artikel
931 Stability of schizophrenic referential communication disturbances over time and across changes in clinical state Docherty, N.M.
 2003
 60 1S p. 168-
1 p.
 artikel
932 Stable elderly patients with psychotic disorders improve with long-acting risperidone Eerdekens, M.
 2003
 60 1S p. 282-
1 p.
 artikel
933 Stakeholder perspectives on sustaining involvement in care for schizophrenia: Autonomy, boredom and decision-making Fischer, E.P.
 2003
 60 1S p. 336-
1 p.
 artikel
934 Standards of antipsychotic use in primary care in Hull, UK Shepherd, C.J.
 2003
 60 1S p. 344-345
2 p.
 artikel
935 State linked quantitative measures of symptomatology, cognition, and brain electrical activity in the clinical treatment of psychosis Schwarzkopf, S.B.
 2003
 60 1S p. 302-303
2 p.
 artikel
936 Stressful life events in recent-onset schizophrenia: Event characteristics and subjective appraisals Horan, W.P.
 2003
 60 1S p. 18-
1 p.
 artikel
937 Stress vulnerability of the rats receiving neonatal administration of interleukin-1 Watanabe, Y.
 2003
 60 1S p. 118-
1 p.
 artikel
938 Striatal dopamine transporter density in first episode schizophrenia assessed with IPT-SPECT Kim, C.E.
 2003
 60 1S p. 243-
1 p.
 artikel
939 Structural brain deviations associated with schizophrenia and psychotic bipolar disorder assessed using computational morphometry McDonald, C.
 2003
 60 1S p. 201-202
2 p.
 artikel
940 Structural brain differences between poor outcome and good outcome patients with schizophrenia Shihabuddin, L.
 2003
 60 1S p. 206-
1 p.
 artikel
941 Structural gray matter brain abnormalities in first-episode early onset psychosis: A voxel based morphometry study in children and adolescents aged ten to eighteen Pagsberg, K.
 2003
 60 1S p. 204-
1 p.
 artikel
942 Studies of the piper rhythm in schizophrenia Lohr, J.B.
 2003
 60 1S p. 254-255
2 p.
 artikel
943 Study of quality of life in first-episode psychotic patients in the period of untreated psychosis Law, C.
 2003
 60 1S p. 338-
1 p.
 artikel
944 Subjective cognitive evaluation in a university student population by cognitive failure questionnaire (CFQ) Stratta, P.
 2003
 60 1S p. 159-
1 p.
 artikel
945 Subjective representation of cognitive deficit measured with cantab in schizophrenia Prouteau, A.
 2003
 60 1S p. 179-
1 p.
 artikel
946 Subjective response to atypical and typical antipsychotics in schizophrenic inpatients Yoon, B.
 2003
 60 1S p. 371-
1 p.
 artikel
947 Substance abuse and recent-onset psychosis Wade, D.
 2003
 60 1S p. 9-
1 p.
 artikel
948 Subtle left-turning bias not altered by antipsychotic treatment and correlated with formal thought disorder in patients with schizophrenia Aldemir, S.
 2003
 60 1S p. 121-
1 p.
 artikel
949 Suicide attempts among patients with psychosis in a Chinese rural community Ran, M.
 2003
 60 1S p. 48-49
2 p.
 artikel
950 Suicide attempts and family history of suicide in schizophrenia Tremeau, F.
 2003
 60 1S p. 51-
1 p.
 artikel
951 Suicide attempts in an African schizophrenia population: An evaluation of risk factors and affected sibpair status Koen, L.
 2003
 60 1S p. 42-
1 p.
 artikel
952 Suicide in “neuropsychologically normal” schizophrenia Shemansky, W.J.
 2003
 60 1S p. 8-
1 p.
 artikel
953 Summer birth and deficit schizophrenia: A pooled analysis from five countries Messias, E.
 2003
 60 1S p. 45-46
2 p.
 artikel
954 Suppressing unwanted thoughts in schizophrenia: Its relation to thought control strategies and schizotypal traits Elua, I.
 2003
 60 1S p. 169-
1 p.
 artikel
955 Swiss GPs and early psychoses: Results from a national survey Simon, A.E.
 2003
 60 1S p. 50-
1 p.
 artikel
956 Switching to aripiprazole monotherapy Kujawa, M.
 2003
 60 1S p. 290-
1 p.
 artikel
957 Symptom and demographic profiles in first-episode psychosis Gelber, E.I.
 2003
 60 1S p. 4-
1 p.
 artikel
958 Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: A one- and four-year prospective study Kurtz, M.M.
 2003
 60 1S p. 142-
1 p.
 artikel
959 Tardive dyskinesia and glucose metabolism Lachaux, B.
 2003
 60 1S p. 360-361
2 p.
 artikel
960 Tardive dyskinesia, glucose and lipids with conventional and atypical antipsychotics Bark, N.
 2003
 60 1S p. 351-352
2 p.
 artikel
961 Target cell-specific modulation of excitatory synaptic transmission by dopamine in the prefrontal cortex Gao, W.
 2003
 60 1S p. 106-
1 p.
 artikel
962 Temporal changes in 5-HT and DA turnover following acute and chronic treatment with typical and atypical antipsychotics Dawson, L.A.
 2003
 60 1S p. 105-
1 p.
 artikel
963 Temporal characteristics of haemodynamic response in planum temporale modulated by laterality of hallucination-like speech Hunter, M.D.
 2003
 60 1S p. 223-
1 p.
 artikel
964 Temporal lobe abnormalities detected in bipolar disorder with magnetisation transfer imaging Bruno, S.D.
 2003
 60 1S p. 190-
1 p.
 artikel
965 4.0 Tesla 1H MRS correlates of neuronal degeneration in the left anterior cingulate and thalamus in first episode and chronic schizophrenic patients Williamson, P.C.
 2003
 60 1S p. 247-
1 p.
 artikel
966 Testing a hypothesis of cerebellar granule cell dysfunction in schizophrenia Paz, R.D.
 2003
 60 1S p. 66-
1 p.
 artikel
967 Test-retest stability of the neurologic examination in stable schizophrenia Jampala, V.
 2003
 60 1S p. 18-19
2 p.
 artikel
968 The adult pattern of neurological signs associated with very preterm birth and their neuroimaging correlates Allin, M.
 2003
 60 1S p. 188-
1 p.
 artikel
969 The affective pathway to psychosis Myin-Germeys, I.
 2003
 60 1S p. 47-
1 p.
 artikel
970 The-1438-A/G serotonin 2A receptor promoter polymorphism affects promoter activity Parsons, M.J.
 2003
 60 1S p. 96-
1 p.
 artikel
971 The antipsychotics and sexual functioning questionnaire (ASFQ): A pilot study evaluating reliability and validity in patients treated with antipsychotics Bous, H.
 2003
 60 1S p. 353-
1 p.
 artikel
972 The apolipoprotein-L (APOL) gene family and schizophrenia: An association study in an irish case-control sample Corvin, A.
 2003
 60 1S p. 93-
1 p.
 artikel
973 The biological subtype hypothesis and case-control differences in schizophrenia research Heinrichs, W.
 2003
 60 1S p. 39-40
2 p.
 artikel
974 The Broset Violence Checklist and predicting assault on an acute psychiatric hospital unit Stewart, R.
 2003
 60 1S p. 184-
1 p.
 artikel
975 The clinical presentation and treatment of two hundred children and adolescents with schizophrenia Ulloa, R.E.
 2003
 60 1S p. 53-
1 p.
 artikel
976 The cognitive dysfunction in the first episode of schizophrenia Prikryl, R.
 2003
 60 1S p. 178-179
2 p.
 artikel
977 The contribution of controlled aspects of semantic processing to verbal memory encoding and semantic fluency deficits in schizophrenia Lowery, N.
 2003
 60 1S p. 144-
1 p.
 artikel
978 The development of a computer-based cognitive remediation program for schizophrenia Morris, S.
 2003
 60 1S p. 326-
1 p.
 artikel
979 The distribution of suicidal behavior and risk factors in patients diagnosed with schizophrenia in a one-year multicenter follow-up study Gogus, A.K.
 2003
 60 1S p. 16-
1 p.
 artikel
980 The effectiveness of the second generation antipsychotics risperidone and olanzapine in schizophrenic patients after switching from conventional antipsychotics or clozapine: A mirror-study Søholm, B.
 2003
 60 1S p. 304-
1 p.
 artikel
981 The effect of atypical antipsychotic drugs in patients with preexisting diabetes Matchett, J.L.
 2003
 60 1S p. 362-
1 p.
 artikel
982 The effect of buspirone, a serotonin1A agonist, on cognitive function in schizophrenia Sumiyoshi, T.
 2003
 60 1S p. 304-
1 p.
 artikel
983 The effect of obstetric complications on neurological development and schizophrenia — A structural equation model in UK birth cohort data Leask, S.
 2003
 60 1S p. 43-
1 p.
 artikel
984 The effect of single-dose risperidone on aromatic amino acid decar☐ylase activity in healthy human subjects measured using [18F]6-fluoro-L-M-tyrosine positron emission tomography Mamo, D.
 2003
 60 1S p. 243-
1 p.
 artikel
985 The effects of antipsychotic medication on neurological examination abnormalities in schizophrenia Goldstein, G.
 2003
 60 1S p. 4-
1 p.
 artikel
986 The effects of antipsychotics on cortical inhibition using transcranial magnetic stimulation Daskalakis, Z.J.
 2003
 60 1S p. 249-
1 p.
 artikel
987 The effects of atypical antipsychotics on elevated expression of integrin αIIβ βIIIα in drug naive, first episode schizophrenic patients Thakore, J.H.
 2003
 60 1S p. 305-
1 p.
 artikel
988 The effects of ketamine and nicotine on brain function during cognition Beason-Held, L.
 2003
 60 1S p. 212-213
2 p.
 artikel
989 The forgotten therapy: Depot neuroleptics in the era of atypical antipsychotics, a community based study Eramo, A.
 2003
 60 1S p. 38-
1 p.
 artikel
990 The functional anatomy of empathy in patients with schizophrenia Lee, K.
 2003
 60 1S p. 226-227
2 p.
 artikel
991 The functional anatomy of forgiveness in patients with schizophrenia Green, R.D.
 2003
 60 1S p. 218-
1 p.
 artikel
992 The functional G-protein β3 subunit (C825T) polymorphism does not influence the efficacy of olanzapine therapy in Basque or Spanish patients Munro, J.
 2003
 60 1S p. 87-
1 p.
 artikel
993 The functional outcome of executive impairments in the psychomotor poverty syndrome: Verbal working memory may mediate the relationship between memory and real-life skills Greenwood, K.E.
 2003
 60 1S p. 137-
1 p.
 artikel
994 The impact of psychiatric symptoms on the capacity of patients to give informed consent Howe, V.
 2003
 60 1S p. 171-
1 p.
 artikel
995 The incidence of schizophrenia: A systematic review Saha, S.
 2003
 60 1S p. 49-
1 p.
 artikel
996 The incidence of schizophrenia in ethnic minorities in London — Evidence for social aetiological factors Murray, R.
 2003
 60 1S p. 47-
1 p.
 artikel
997 The incidence of the serum creatine kinase elevation in schizophrenia and schizoaffective patients during antipsychotic treatment Reznik, I.
 2003
 60 1S p. 366-
1 p.
 artikel
998 The influence of inequality on the incidence of schizophrenia — An ecological study Boydell, J.
 2003
 60 1S p. 33-34
2 p.
 artikel
999 The initial manic prodrome: Implications for early detection and intervention Ward, J.L.
 2003
 60 1S p. 29-30
2 p.
 artikel
1000 The integrated psychological treatment (IPT) for patients with schizophrenia: Evidence of effectiveness during program implementation in various sites in Quebec, Canada Briand, C.
 2003
 60 1S p. 320-
1 p.
 artikel
                             1110 gevonden resultaten
 
   volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland